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Abstract
With the ever-increasing complexity of spacecraft, the real-time data and state of
health analysis by mission operators becomes an intricate process subject to the pitfalls of
error-prone human reasoning techniques. If even detected, characterizing an anomalous
state on the spacecraft can take substantial amounts of time thus reducing overall
operational efficiency and possibly even jeopardizing the mission. This research
specifically addresses the state-of-health analysis of biological payloads flown on NASA
missions such as GeneSat-1 and PharmaSat. The complex engineering systems and
timely anomaly resolution required for maintaining life support in these biological
spacecraft makes human diagnosis on its own insufficient.
To address these challenges, this project incorporates the use of model-based
reasoning for managing anomalies found on board biological microsatellites. A
spacecraft payload model was constructed with behaviors relevant to biological sample
growth and the associated micro fluidic life support system. A suite of algorithms was
applied to the model for computing diagnosis conjectures on detected anomalies.
Implemented in MATLAB/ Simulink and designed for use as a ground-based tool for
human operators, this system focused primarily on mission operator decision support.
The system was developed via analysis of GeneSat-1 flight data and with a
biological test bed which emulated the growth characteristics of the spacecraft. It was
later integrated into the ground segment of the PharmaSat space system and verified with
its flight data after launch. Results gained from experimentation validated the tool’s
ability to reason on unanticipated anomalies, its speed of analysis, and its ability to
augment a human operator for real-time anomaly characterization and decision support.
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1

Introduction

1.1

Motivation
The value of any space mission is derived from the data products produced and

services provided by the spacecraft. Characteristics inherent to space flight such as a
dynamic global view, location above the atmosphere, microgravity, and radiation
environments allow the spacecraft to generate and disseminate unique data which can be
exploited via commercial, civil, and military avenues [1]. For example, spacecraft are
routinely used for global communications, imaging, navigation, solar system exploration,
and in-situ experimentation.
The primary appeal of a spacecraft is also its biggest drawback. The extreme
nature of the space environment and the long distances from which they operate impose
rigorous design considerations and thus increase the complexity of these systems. This
raises the likelihood of anomalous behavior in the system ultimately warranting a method
for detecting, diagnosing, and resolving these anomalies efficiently. Additionally given
that the spacecraft operates remotely, it is impossible to inspect it in person should an
anomaly be detected; the ability for human operators to reason on the system’s wellbeing is purely dependent on the data sent back [1, 2].
Techniques aimed at timely anomaly management are usually procedural and
involve large numbers of system experts who offer their invaluable insight. However,
since human reasoning techniques can be costly and error-prone, the result can be
incomplete or incorrect resulting in a critical inefficiency in mission operations [1].
Streamlining missions operations is paramount since they can account for 25-60% of total
project costs. [3]
1

1.2

Reasoning Approaches
In an effort to aid operators in the difficult task of accurately assessing the state of

a spacecraft, a formalized reasoning theory of fault detection and diagnosis can be
applied to streamline anomaly management. One such theory is derived from the field of
model-based reasoning (MBR). In MBR, reasoning conjectures are computed from
fundamental design knowledge of the engineering system. This technique, which is often
referred to as reasoning from first principles, relies on the use of a model that describes
component or subsystem level behavior, interconnectivity, and performance. Given
certain constraints and inputs, this model can be used to simulate outputs that are
expected from the real system. The real system typically generates its outputs using
sensors and telemetry. Comparing the expected and actual outputs of any system is a
common technique in MBR fault detection; any discrepancy between the two can be a
potential anomaly within the system and is cause for deeper investigation.
The investigative process of finding discrepancies in simulated and real data is
called detection. From there the user can compute diagnosis conjectures for anomalous
components or subsystems. Taking this notion a step further, the system can be designed
to change its state based on the diagnoses to either remedy the anomaly or minimize its
effects. This is known as resolution. While the states from a model created for use with
the MBR framework could be evaluated manually by a human, the timeliness and
efficiency does not scale to even modestly large and complex systems. Implementing
model state evaluation as well as detection, diagnosis, and resolution on a computer can
significantly reduce computation time.

2

Applications of MBR have been ubiquitous in a wide variety of engineering
disciplines including aerospace, industrial design, biomedicine, and automotive design.
Though the implementation of the technique is varied, many similarities exist between
specific applications. Since MBR relies on representing the behavior of the system
through individual models of its components, system models are typically networks of
interconnected components; each of which is assigned a ‘plant model’ equation. This
level of abstraction creates a common architecture which generally varies only by
implementation and complexity. For example, an MBR system which involves the
circuit health analysis in avionics packages [4] once abstracted has many common
elements as a more complex model-based automotive diagnostics package [5] involving
hundreds of electrical, mechanical, and software- based components. For example, once
component-specific behaviors are captured, an integrated circuit’s truth table can be
handled identically as the performance of an automobile’s adaptive suspension system.
The use of MBR is a particularly interesting solution for the autonomy of
interplanetary spacecraft. A study conducted in 1995 between researchers at NASA’s Jet
Propulsion Laboratory and Ames Research Center called NewMAAP (New Millennium
Autonomy Architecture Prototype) applied MBR techniques to a simplified simulated
model of the Cassini spacecraft, NASA’s most complicated spacecraft to date. An aspect
of this research focused on NewMAAP’s fuel system and thrusters; the system was able
to dynamically adapt after detecting faulted fuel system components to deliver the
necessary thrust in critical maneuvers such as an autonomous orbit insertion [6]. Figure
1.1 shows a model of the NewMAAP fuel system. NewMAAP’s application of MBR to
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fluidic components on a spacecraft is of particular interest given the research presented in
this thesis.

Figure 1.1 – Simplified Schematic of Cassini Spacecraft Propulsion System – In this
example, the circled valve is faulted resulting in actuation of the second thruster [6]

The success of the NewMAAP research led to notable work pertaining to the
Livingstone system flown on the NASA New Millennium Program’s Deep Space One
(DS-1) mission [6, 7]. Launched in 1998 and retired in 2001, DS-1 was a flight test of
numerous technologies including an ion propulsion engine, autonomous navigation and
imaging (Autonav), and a remote agent responsible for onboard anomaly management.
The Livingstone Remote Agent Experiment (RAX) demonstrated a new approach
to spacecraft command and control. By incorporating the autonomous remote agent into
DS-1’s flight software, operators were able to rely on the agent to achieve particular
goals. Since the operators did not know the exact conditions on the spacecraft, they did
not tell the agent exactly what to do. Rather, using this model-based system they could
specify what goals to achieve in a period of time as well as how and when to report back.
Even in the event of an anomaly onboard the spacecraft, the remote agent would make a
best effort to work around or resolve the anomaly to complete the goal set by operators.
Figure 1.2 illustrates the architecture of the entire model-based system.

4

Figure 1.2 – Livingstone Architecture Diagram – The model shown in Figure 1.1 and
the actual spacecraft are adapted into the Livingston architecture. The controller uses
each one’s states to compute which inputs are appropriate to achieve a given goal. [6]

Another aerospace application of interest was the use of MBR on the fuel system
of an F/A-18 Hornet fighter jet. This work focused on using MBR on a system far more
complex than most demonstration systems to model the fuel flow through the aircraft.
The model incorporated 89 components in 13 subsystems and took a total of 3 years to
reverse engineer. Though not used in real-time flight scenarios, it was proven that even
an exhaustively large model of fluidic components could be used for MBR applications
[8]. Figure 1.3 illustrates the aircraft’s fuel system.

Figure 1.3 – The F/A – 18 Fuel System – Illustrated here is the interconnectivity of the
fighter’s main fuel system components. Capturing the behavior of these components and
their connections was the heart of the research project. [8]
5

Not only applicable in aerospace, MBR has been used in industrial control
applications. Of particular interest to this research are the applications involving control
of biological processes. These applications by definition have modeled their biological
sample and can derive predicted states analogous with those measured in the real system
to perform high level control tasks. There has been extensive work in maximizing the
manufactured volume of yeast, and a good example of this work is the automation of
baker’s yeast production. A model estimating the key state variables in the yeast’s
bioprocesses guides the control algorithm for administering the maximum amount of
glucose possible without negatively altering the yeast’s metabolism to achieve the most
efficient growth [10]. Another example of MBR used in bioprocess control is the
regulation of insulin dosage to diabetic patients. Given input constraints such as the
patient’s current state of health, time of day, types of meals eaten, etc. a model is
generated with an expected amount of insulin required. Compared to a measured blood
glucose level the system reasons on the predicted and expected values and doses the
patient accordingly. Suggestions and diagnoses are offered to the user should there be an
unexpected discrepancy in predicted and actual blood glucose values [11].

1.3

Objectives
The objective of this work was to investigate the use of MBR techniques to

increase mission operators’ awareness of a biological microsatellite’s state of health. A
spacecraft payload model was constructed with behaviors for biological sample growth
and the associated micro fluidic life support system. A suite of algorithms was applied to
the model for computing diagnosis conjectures on detected anomalies and verified via
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experimentation. Implemented in the MATLAB/Simulink computational package and
designed for use as an on-console tool, this system focused primarily on near real-time
mission operator decision support.
To the author’s knowledge this is the first ever opportunity to implement MBR as
an anomaly management system for the biological payload of a spacecraft. Additional
objectives of this project were:
•

Integration of MBR with a real space system and mission operations
ground segment,

•

Development of a representation of fluid flow modeling in between
microfluidic components,

•

Creation of reasoning strategies to address time-based dynamic behaviors
in MBR systems.

1.4

Contributions
In order to satisfy the objectives of this project and to motivate follow-on work,

contributions made include the following:
•

Application and experimental verification of the MBR system in the
context of the NASA PharmaSat mission,

•

Application of MBR modeling techniques to a new engineering system
including microfluidic systems,

•

The extended development of graphical modeling tools and techniques
which facilitate future MBR applications.

7

•

A gained understanding of biological handling, preparation, and use in
experimentation for future Santa Clara University space flight missions.

1.5

Reader’s Guide
This thesis is composed of 5 main chapters and subsequent appendices. Chapter 1

discusses the research project’s motivations, reasoning approaches, objectives,
contributions and this reader’s guide. Chapter 2 describes the GeneSat-1, PharmaSat, and
biological test bed engineering systems with respect to the biological experiment that
each one of these carries out. The level of detail used is moderate but necessary because
Chapter 3 discusses the modeling of these systems in greater detail. This chapter also
outlines the MBR technique and how it is applied to this decision support system.
Chapter 4 presents experimental results and Chapter 5 gives a summary of the work done
as well as conclusions and suggestions for future work.
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2

Experimental System Design
This chapter describes the primary test beds used during the research project.

Included are descriptions of the GeneSat-1 and PharmaSat satellites along with a
prototype biological test bed used for bench testing. GeneSat-1’s flight experiment data
was used to refine the research project’s modeling and design approaches while
PharmaSat was still under development. After PharmaSat’s successful launch its
experimental data was used as a primary means of verification of the anomaly
management tool. Since injecting anomalies into PharmaSat to test the tool was not
possible, a ground-based biological test bed was developed to facilitate testing and
diagnosis verification. The research in this thesis is focused primarily on the anomaly
detection and diagnosis of the biological payloads of these systems which includes
modeling of their functionality; hence, an overview of the functionality of these systems
is presented here.

2.1

GeneSat-1
The Genesat-1 (Figure 2.1) technology demonstration mission validated the use of

research quality instrumentation for in situ biological research and processing in a space
environment. After its launch on December 16, 2006 all primary science and engineering
test objectives were successfully tested after one month of operation [15]. The data
products from the GeneSat-1 mission were used in this research project to facilitate initial
biological and microfluidic modeling which is presented in Chapters 3 and 4.

9

The GeneSat-1 mission patch

The GeneSat-1 Microsatellite and the PPOD deployment device
Figure 2.1 – GeneSat-1

2.1.1

Mission Overview
The GeneSat-1 mission was the first microsatellite to incubate living bacteria in a

microgravity environment. The study involved observing the growth of E. coli (a
common and well-understood laboratory strain bacteria) over the course of 96 hours. The
bacteria were provided nutrients, a steady heat source, and humidified oxygen in a sealed
container in the spacecraft’s payload to enable growth. After having determined the state
of the satellite was appropriate (a stabilized attitude with an established microgravity
environment), satellite operators issued the spacecraft a command to administer heat and
nutrients to the biology. Growth was autonomously monitored by the spacecraft and
measurements were down linked by satellite operators over the course of the mission
lifetime.
The spacecraft also served as a technology demonstration aimed at establishing
small satellites as a low-cost solution for biological research in space. Many
collaborators from local industry and academic institutions were involved in the
development of various flight and mission systems. Students from California Polytechnic
State University, San Luis Obispo developed the P-POD deployment device which
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protected the satellite during launch and ejected it into orbit once the appropriate altitude
was reached. Stanford University was involved in prototyping components of the
biological payload and bus subsystems including optics, communications, and structural
elements. Santa Clara University developed all mission operations subsystems for
command, control, and data analysis of the spacecraft for on-orbit operations as well as
providing a team of all student operators; a first for a NASA mission.

2.1.2

Data Products
With respect to the biology experiment, two main data products were produced:

optical density and growth fluorescence measurements. Both of these readings were
taken using a set of custom optics devices – essentially an array of Light Emitting Diodes
(LEDs) and corresponding detectors. The experiment carried 12 such arrays, one for
each 110µl well containing biology. The data collected from the spacecraft was
compared to a control experiment concurrently executed on the ground – thus the main
variable in growth between the two could be likened to microgravity effects.
The optical density measurement provided a quantitative representation of the
well turbidity. An LED was shone through an individual well and the amount of light
coming through the other side was measured by the detector. This meant that the
quantity of light absorbed by the well could be correlated to a cell population count.
Repeated measurements provided a growth curve of the bacteria over time.
The experiment also focused on measuring the bacteria’s metabolic rates by
measuring its Green Fluorescence Protein (GFP). When excited by an external UV light
source, this genetically engineered protein produced an optically visible green light, the
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brightness of which corresponded to a metabolic state thus indicating how well that
specific cell was growing. With enough cells glowing, the combined light in an
individual well could also be captured by the detector. The experimental flight data is
shown in Figure 2.2.
Other telemetry of interest included payload state-of-health and power
management data. Elements such as well plate temperatures, air pressure, and relative
humidity values were essential in verifying that the environment the bacteria were
GeneSat-1 Experiment Optical Density Data - All Wells
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GeneSat-1 Experiment Fluorescence Data - All Wells
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Figure 2.2 – 96 Hour Experiment Data – GeneSat-1 Flight Unit
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growing in was optimal and corresponded to the control experiment on the ground.
Maintaining the ideal temperature for bacteria growth required significant amounts of
power to drive a heater located on the well plate. Budgeting power was therefore of great
importance during the experiment leading to the constant monitoring of battery voltages
and solar panel currents. Power was also needed to drive the optics as well as other
sensors in the payload subsystem, thus placing additional importance on these telemetry
values.
GeneSat-1 Payload Temperatures from Payload Health&Status file
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Figure 2.3 – Experimental Support Telemetry – GeneSat-1 Flight Unit
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The autonomous state-of-health monitoring of this payload telemetry as well as
biological growth information during on-orbit operations for future heritage missions was
the inspiration for this research project. The author of this thesis served as a primary
operator for the spacecraft, and it is through this experience that there arose a need to
develop a system that could accurately detect and diagnose anomalies in near real-time
based only on available telemetry. The GeneSat-1 flight data was used in initial testing
of system modeling and algorithm verification. Being able to use the biological growth
data as a form of feedback for nominal spacecraft health was invaluable in the creation of
this decision support tool.

2.2

PharmaSat
With the technology successfully validated in the GeneSat-1 mission, the follow-

on PharmaSat (Figure 2.4) experiment was immediately pursued. Based on GeneSat-1’s
heritage, a more complex PI driven biological experiment was developed to fly in the
same chassis using essentially the same bus but with an almost entirely reworked (and
more intricate) payload. The increased complexity to accommodate the experiment
resulted in the use of more components and consequently generated more telemetry. This
made an operator’s interpretation of the spacecraft’s condition in orbit more timeconsuming and prone to error. This research project was aimed at reducing this
reasoning time and aiding the operator’s understanding of the payload’s state-of-health.
The PharmaSat system described in this chapter was modeled and the data downloaded
after launch was used in an end-to-end verification of the anomaly management tool.
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Successfully launched on May 19th 2009 from Wallops Island, VA, PharmaSat
was a secondary payload aboard a Minotaur I rocket co-manifested with TacSat-3
(developed by the Air Force Research Laboratory). Mission operations were conducted
by the Robotic Systems Laboratory at Santa Clara University. PharmaSat’s primary
mission ended within a few weeks of launch when the experiment was complete and all
pertinent data was downloaded from the spacecraft.

Top – Assembled Unit W/O Solar Panel, Exposing
Fluidics Valves. Left – Payload Assembly.
Right – Installed Payload Assembly.

PharmaSat Mission Patch

TacSat-3 and PharmaSat launch
Figure 2.4 – PharmaSat

15

2.2.1

Mission Overview
The PharmaSat experiment and flight system was designed to measure the

influence of microgravity on yeast resistance to an antifungal agent. The PI-led science
ultimately focused on determining the quantity of antifungal drugs needed to be
administered to humans who develop a yeast infection on long-term space flights, a
commonly reoccurring illness.
The self-contained and autonomous nanosatellite featured tri-color optical
detectors, an intricate microfluidic network, environmental control, and power
management subsystems. Flying these additional components in the same size package
required advances in miniaturization and integration strategies. The experiment was
designed to be executed the same way as GeneSat-1; with orbit stability and microgravity
environment conditions to be met before execution. The spacecraft autonomously
maintained and recirculated the payload fluids at 5°C (to prevent freezing in orbit) until
the ‘Start Experiment’ command was received, after which it administered a growth
media to the yeast, prepared three different concentrations of antifungal solution, and
after a period of about 40 hours delivered the antifungal to the yeast which had reached a
scientifically critical point in its growth curve. Like with GeneSat-1, the data was sent
back to Earth where Santa Clara University student operators were on console evaluating
the spacecraft’s state of health as commands were being sent.

2.2.2

Biology Experiment
While similar to GeneSat-1’s biological experiment on a high level, PharmaSat

not only incubated its fungus specimen for the duration of the flight, but also challenged
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its resistance to different concentrations of a drug created to treat that specific strain.
Much like the E. coli bacteria flown on GeneSat-1, the Saccharomyces cerevisiae strain
of budding yeast is a fundamentally well-understood laboratory specimen common to
biological research, making it a good selection for this mission.
The well plate containing biology was divided into five rows, each containing 12
wells for a total of 60 wells. One row was used as an optical calibration baseline and was
not administered any media. The other four were grown simultaneously. One row acted
as a control (no antifungal), and the other three were given low, medium, and high
concentrations of the pharmacological drug. Each well had two 1 µm filters on the input
and output channels to allow media to flow through while keeping the biology in the
wells. Figure 2.5 illustrates the custom well plate.

Figure 2.5 – PharmaSat Well Plate Illustrating the 5 Biology Well Banks

The experiment execution was broken down into two subsystems, Payload and
Fluidics; each of which was divided into phases that commenced only after the conditions
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of the previous phase had been satisfactorily reached or a timeout had occurred. Each
subsystem was driven by its own PIC 18F microprocessor and consequently its own state
machine though both were synchronized to work together. There were a total of 7 such
phases in the payload identified with standard letters, and 12 phases in the fluidics
identified with roman numerals. An overview of the phases of both subsystems can be
seen in Figure 2.6.
PharmaSat Payload Operational Phases

Payload
Powered

Timeout 1
and
Battery fully charged

Timeout 2
and
Battery fully charged

B
Fluidics
Heating

A
Sampling

Main
Payload

Normal Experiment Timeouts:
Compressed Experiment Timeouts:

Fluidics
Powered

15d
1h

C
Card
Heating
10h
1h

Fluidics Heating
Started

I
Recirculation

Fluidics
System

Card Temp Stabilized
or Timeout 3
and
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II
Recirculation

Optical Condition
or Timeout 4
and
after 60th well.

Timeout 5 Timeout 6

D1
Exp
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1h
1h

48h
5h

Start
Fluidics

Start antifungal phase

III-VI
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VII-XI
Antifungal

D3
Exp
4h
4h

E
Post Exp
44h
1h

XII
Post Exp

Time
Bus Powered
on Deployment

Note: A PL phase transition can
be triggered with the PLSetPhase
Command.

Figure 2.6 – PharmaSat Experimental Phases – Payload and Fluidics

Phase A was initiated shortly after deployment of the spacecraft from the P-POD
and involved collecting health and status data for a maximum of 15 days as the spacecraft
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stabilized. The fluidics system circulated growth media in phase I with the payload
maintaining a keep-alive heater setting at 5°C to prevent the fluid from freezing. When
mission management, engineers, and operators determined that the spacecraft had
stabilized, was healthy, and had achieved a microgravity environment, phase B
commenced with the heating of the fluidics to 19 °C via an explicit command sent from
the ground. The delayed fluid heating was done so as to save power, but was necessary
to avoid cold-shocking the yeast when the media was administered later in the
experiment. A heat stability flag was set for the fluidics once the set point temperature
was reached. Upon the setting of this flag the payload controller activated the card heater
to maintain the temperature of the yeast at 27 ± .5°C. A subsequent card heat stability
flag triggered the fluidics controller to administer growth media to the yeast (Phase D1/
III). In the 40 hours that the yeast cells were actively growing, the fluidics system phases
IV-VI prepared the high and low concentrations of antifungal to be administered.
The second half of the experiment (D2, D3, and E) started by dosing the control
bank with growth media and the low concentration antifungal to its designated bank. The
medium concentration was prepared and administered along with the high concentration
dilution. Park and shut-down phases soon followed for the fluidics system while the
payload maintained fluid and well plate temperature control and monitored growth for the
remainder of the experiment.
The growth measurements were taken using a tri-color LED-detector combination
similar to GeneSat-1; however the detector was spectroscopic and measured the biology
in red, green, and blue absorption values. The growth media was infused with Alamar
Blue, a substance which oxidized from blue to pink as the yeast grew. The amount of
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pink in the well therefore indicated metabolic state of the biology much like fluorescence
did with GeneSat-1’s E. coli. Since the oxidized pink fluid was only composed of red
and blue color components, the absorbed green value was a direct measure of well
population. Experiment test data is shown in Figure 2.7, displayed with the same
telemetry analysis used by satellite operators after launch.
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Figure 2.7 – PharmaSat Ground Optical Test Data – Tricolor LED readout for one
well. The entirety of the experiment can be backed out from this data. The initial steep
drop in values corresponds to well dosing. A second small step (~10^5 counts) indicates
a second dosing. The curves indicate the transition from Alamar blue to an oxidized pink
as the yeast grows and metabolizes the growth media. Note the red component generally
increasing while the blue slowly decreased. The green component can be normalized to
show cell population.
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2.2.3

Payload Components
Although the spacecraft’s payload consisted of many electrical and mechanical

components, only those directly responsible for the positive outcome of the experiment
are modeled, and therefore these are the ones discussed in this section. Many of these
components were never intended for space flight let alone proven by heritage; therefore
they are of particular interest in this anomaly management study.
The fluidics system was composed of 2 pumps, 13 valves, 5 waste bags, and 4
media bags as well as over 1 meter of tubing in between these components. These were
all actuated by the fluidics PIC microprocessor depending on what phase the experiment
was in. Passive components included a check valve, bubble trap, hose connectors, and
springs located inside the tubing to mitigate kinking. A diagram of the fluidics network
is given below in Figure 2.8.

Figure 2.8 – PharmaSat Fluidics Network Diagram
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There were two different COTS pumps in the fluidics network. It is worth noting
that neither of these was originally intended for space flight. A diaphragm pump
(designated P-1 in Figure 2.8) is used for high flow rate pumping tasks such as
recirculation and antifungal preparation, and a stepper pump (P-2) is used for highly
precise tasks such as dispensing media and antifungal dilutions to the wells. Figure 2.9
shows the pumps used for the experiment.

(a) Diaphragm Pump

(b) Stepper Pump

Figure 2.9 – PharmaSat Fluidics Pumps – (a) The diaphragm pump from KNF
Neuberger pumps 50 mL/min (b) The stepper pump from The Lee Co. pumps 50 µL in
500 steps thus having .1 µL precision
PharmaSat’s 13 microfluidic valves were also off-the-shelf products from The
Lee Co. and have no previous space flight history. These were all 3-way solenoid valves
with common, normally open (NO), and normally closed (NC) ports. No voltage over
the leads kept the common and NO ports connected, while a 12V potential drove the
solenoid over to connect the common and NC ports. Two of these valves had sealed NO
ports, thus operating essentially as on/off valves. They were all rated to a 15 psi port
differential while the pumps operated at 10-15 psi of instantaneous head pressure;
therefore pumping fluid to a closed port would most likely result in a leak at the tubing
connection or outright failure of the valve. Figure 2.10 shows a CAD drawing of the
solenoid valves.
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Figure 2.10 – 3 Way Microfluidic Solenoid Valves

The heating elements used in the payload were strip heaters custom built from
vendors Watlow and Minco. Two card heaters were located on each side of the well
plate attached on aluminum heat spreader plates using a pressure-sensitive adhesive. The
heaters conformed to the size of the well plate with holes located over each well to avoid
interference with the optics. A total of six temperature sensors were embedded in the
heat spreader plates as part of the closed loop control system. Similar strip heaters were
wrapped around the fluidics reservoirs for thermal control with three temperature sensors
providing feedback. Figure 2.11 shows a CAD drawing of the aluminum heat spreader
plates and card strip heaters.

Figure 2.11 – Well Plate Heating System
The storage bags selected for the experiment were American Fluoroseal cell
containment bags made of thermo-formed Fluorinated Ethylene Propylene Copolymer
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(FEP) and were excellent at containing non-corrosive biological media. Though used
extensively on the ground in laboratory work, these too have no previous space flight
history. A total of 9 of these bags were used on the spacecraft for containing growth
media, antifungal dilutions, and waste fluids. The tubing connecting all media bags and
fluidics components was a 1/16” ID Tygon hose commonly used in a variety of
laboratory and industrial applications. Figure 2.12 shows the entire payload assembly
with the various components discussed in this section visible.

(a) Top-Down Assembly View
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(b) Close-Up View
Figure 2.12 – PharmaSat Payload Assembly – (a) Various components are visible
here, including the solenoid valves (bottom), tubing, media bags, and payload circuit
board. (b) Valves, tubing, and stepper pump shown in the package.
This thesis work focused on applying MBR to the engineering system described
in this section. The components discussed here were modeled and compiled into a
system description used for evaluation of healthy and anomalous scenarios in the
PharmaSat payload. A detailed description of modeled components can be found in
Chapter 3 and results of their implementation are presented in Chapter 4.

2.2.4

Data Products
The primary data produced from the PharmaSat mission pertained to the

biological growth in the payload. Comparing the behavior of the yeast as it grew on orbit
with that of the ground-based control experiment offered insight into the effects of
microgravity on living organisms. A wealth of supporting engineering data was also
generated and downloaded from the satellite as a means of monitoring the health of the
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satellite itself. Figure 2.13 shows an example of yeast growth after antifungal dosing in
the measured constituent red, green, and blue colors from the flight experiment.
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Figure 2.13 – PharmaSat Antifungal Concentrations – An increase of antifungal
concentration did not permit the yeast cells to grow. The lack of curves in the high
concentration plot indicates that the Alamar Blue in the growth media was not
metabolized by any growing cells and therefore did not become pink. A slight curve at
the end of the well with medium concentration indicated delayed and severely stunted
growth. Low concentrations yielded slightly inhibited growth compared to not using any
antifungal at all. An unfed well displays no changes throughout the experiment.
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As illustrated in Figure 2.5, the biological well plate contained 4 banks of 12
wells each that were injected with a different amount of the antifungal agent after the
yeast cells had started to grow. An operator looking at the growth data shown in Figure
2.13 would need to be able to interpret the plots to understand whether or not the
biological experiment is behaving as expected. Such an understanding could speed the
troubleshooting process significantly if a specific symptom was found and identified for
the NASA team. In the context of this research, determining whether or not a biological
well was successfully dosed with any fluid (regardless of antifungal concentration) is of
great importance. A failure of one of the many components in the payload would
eliminate the possibility of any growth, let alone the subtle differences in growth rates.
The approach used for performing this determination autonomously is covered in Chapter
3 with results shown in Chapter 4.
Significant amounts of engineering data were also used to assess the health of the
spacecraft throughout the experiment. An operator who is looking at the data for the first
time would need to understand the constraints in which certain telemetry values would
need to fall. Sensor readings that fall out of the expected range would need to be quickly
identified so potential work-around solutions could be implemented.
A mission operator who is analyzing the data shown in Figure 2.14 would need to
understand what they mean and whether or not the spacecraft’s payload is operating
nominally. For example, the payload card temperatures are shown to be oscillating
between 5 and 15 °C in the beginning of the experiment. This behavior is due to
temperature fluctuations on orbit as the spacecraft cycles in and out of eclipse.
Downward cooling trends are evident twice in the experiment; where temperatures
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dropped to the minimum allowable at 5°C. If the automatic temperature controller
malfunctioned, the temperature would have continued dropping past the allowable
minimum limit, possibly having negative consequences with the biology. Likewise
fluidic temperatures were maintained above 5°C to prevent freezing. Once the
experiment was underway, temperatures were held with a greater precision, requiring a
tighter tolerance on acceptable bounds.
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Figure 2.14 – PharmaSat Payload Health Data – Telemetry values are shown here
from the PharmaSat flight experiment.

Payload humidity and pressure was also of particular concern for this experiment.
Though some oscillation was visible due to thermal effects as the spacecraft orbited the
Earth, values remained relatively consistent. A significant depressurization or
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uncharacteristic humidity would likely void the experiment and consequently the
mission.
A full description of flight data and its use in verifying the anomaly management
tool is presented in Chapter 4. Depending on the data and which sensor it came from
custom parameters were assigned to monitor their values as the mission progressed. For
example, it was crucially important to understand the rates at which growth values
changed since this directly indicated the health of the yeast. Therefore, rather than
measure absolute values, the changes in slope of the plots were computed and reasoned
on. In the case of onboard temperatures, as long as their values fell within a certain
bound, the payload was considered healthy. The bounds changed as the experiment
progressed, and the anomaly manager (much like an operator sitting on console) applied
the relevant bounds to reason on payload health.

2.3

Biological Testbed
To facilitate interactive testing of the MBR software with actual hardware, a

biological test bed was created to emulate similar behaviors and features seen in
GeneSat-1 and PharmaSat’s payloads. Introducing anomalies into NASA flight hardware
for testing the anomaly management software was clearly not an option; therefore, this
test bed acted as a way to verify detection and diagnosis algorithms while introducing
known anomalies. While not intended for space flight, the goal was to prototype an
analogous biological experiment using similar, if not the same components and
techniques. In order to make the prototype ‘interesting’ with respect to anomaly
management, more components were used than necessary to accomplish the same
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experiment. The overall experimental complexity of this prototype was in between that
of GeneSat-1 and PharmaSat, and there are elements which drew from both missions.
The biological experiment chosen was inspired from PharmaSat’s science. The
same S. cerevisiae yeast strain used for the flight was selected for this experiment. It is
easy to culture, completely harmless, and behaves analogously to PharmaSat’s biology.
This makes it possible to conduct the same type of 96-hour experiment since this strain’s
growth rates are essentially the same. In the interests of scoping the project, the
introduction of antifungal dilutions was left as future work.
The yeast’s growth was measured using a technique similar to that of GeneSat-1
which used LED-photodiode combinations to measure physical light levels as a function
of well turbidity and consequently biology population. Infrared (IR) wavelengths were
chosen to facilitate filtering of indoor laboratory lighting. Covering the wells completely
or working in darkness was less convenient and unnecessary for this experiment.
The well plate designed for the experiment used similar concepts as those seen in
GeneSat-1 and PharmaSat, but focused on an inexpensive, easy to manufacture, and
reusable design to facilitate testing. Figure 2.15 shows a CAD illustration of the well
plate design.

Figure 2.15 – Biological Prototype Well Plate
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Made of optically clear machined acrylic the well plate contained 6 wells at 400
µL each. The assembly was composed of three main components; the well plate itself
and two covers. Each well was sealed with a pair of o-rings and the entire assembly was
tightened down with three bolts. The input and output ports were tapped to allow a luerlock adaptor to thread into the well plate. These adaptors allowed re-usable syringe
filters to be quick-fitted onto the wells so as to isolate the biology sample only to the
wells. The filters chosen had a 1.2 µm pore size. In contrast PharmaSat has 1 µm pore
sizes allowing similar flow through the wells, but the embedded filter design of its well
plate did not allow for re-usability. Replacing the syringe filters and sterilizing the
prototype’s plate in a diluted bleach bath was all that as needed for a quick turn-around to
start a new experiment.
The well assembly sat in between two aluminum heat spreader plates with a
Minco strip heater attached via silicone glue. The spreader plates not only housed the
heater and its 4 associated temperature sensors but also the 6 IR LEDs and 6 photodiodes
used for well turbidity measurement. The photodiodes were run through a passive buffer
circuit for signal conditioning and amplification. Those voltage outputs as well as those
of the temperature sensors were interfaced to a set of analog-digital converters which
passed the data to a BASIC Stamp microcontroller responsible for temperature control
and telemetry output. Consequently, the well-plate heater was actuated with this
controller. A laptop running a MATLAB script was connected to the microcontroller
and recorded the telemetry output for the duration of the experiment. An image of the
heater plates and sealed well biological wells is shown in Figure 2.16.
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Figure 2.16 – Biological Wells and Heater Plates

The fluidics network consisted of 1 pump, 4 solenoid valves, and 2 media bags all
of which were interconnected with Tygon tubing. To better emulate the behavior of
PharmaSat’s experiment, the same pump, valves, and media bags were selected for the
prototype with only a larger diameter of the same type of tubing used to facilitate the
pumping of fluids. The components were actuated via a second BASIC Stamp micro
controller. This Stamp was also responsible for sending state information to the
telemetry microcontroller for the relaying of data to the laptop recording the information
nearby. In the interest of scoping and costs, only the KNF Neuberger diaphragm pump
was used in the experiment, since the .1 µL precision of the Lee Co.’s stepper pump was
unnecessary and its use would have doubled the cost of the prototype itself. The layout
of the prototype’s fluidics network is shown in Figure 2.17. Full documentation
including source code and electronic schematics can be found in Appendix A.2.
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Figure 2.17 – Prototype Fluidics Network Layout
The experiment phases were designed to emulate those of PharmaSat, namely the
use of a similar event driven state-machine for actuating components such as pumps and
valves. Analogous recirculation phases were used, with heated and non-heated sub
phases. The major difference was that the fluidics were not heated since they were
maintained at room temperature in the laboratory therefore cold shocking the biology was
not a concern. Upon starting the experiment (a physical switch was thrown) the growth
media was recirculated as the well plate reached 80 °F (the same as PharmaSat’s set
point). The media was then administered to each pair of heated wells by actuating the
appropriate valve for a short duration of time and driving the pump. Over the course of
the 96 hour experiment the banks were each dosed once more to provide additional
nutrients and further increase the growth curve. Telemetry readings were taken every 15
minutes and relayed to the nearby computer. Figure 2.18 shows an image of the
complete biological prototype.
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Figure 2.18 – The Biological Test Bed

2.4

Chapter Summary
Several engineering platforms were used in the course of this thesis research to

validate approaches and concepts developed in the application of MBR to a biological
microsatellite payload to increase mission operator efficiency. The science and
engineering data returned from the GeneSat-1 mission helped inspire the work done for
this research project and served as an initial starting point in the decision support tool’s
development. Applying lessons learned from operations conducted in this biological insitu mission helped drive the requirements for future follow-on missions such as
PharmaSat, the target platform for the research presented here. To facilitate interactive
testing of the MBR software with actual hardware, a biological test bed was created to
emulate behaviors and features seen in GeneSat-1 and PharmaSat’s payloads.
The increased complexity seen in the payloads of these spacecraft along with the
use of non-flight rated components led to an increased probability of anomalous behavior
while in orbit. This also raised the difficulty in accurate real-time detection and diagnosis
of anomalies for the operator, further justifying an investigation into streamlined
characterization of such possible anomalies.
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3.

The Model - Based Reasoning System
This chapter outlines the application of Model-Based Reasoning (MBR)

techniques in the context of a biological nanosatellite application. After summarizing the
theory of MBR and relevant Anomaly Management (AM) extensions used in this
research, the chapter describes the tool developed, modeling approach for fluidic
components, and the graphical modeling environment used to accomplish this. Lastly,
the implementation of the overall system in PharmaSat’s ground segment is shown.

3.1

Experiential Anomaly Management
Given only a description of how a system is meant to perform and an observation

of the system’s actual behavior, an inconsistency between the two can be characterized as
an anomaly. Historically the characterization of anomalies in engineering systems has
been performed via human-based experiential reasoning techniques. Humans directly
involved with the system in question use their own expert knowledge combined with
loose knowledge bases in the ways of plans, procedures, documents, etc. to intuitively
create a list of possible faults to diagnose an anomalous behavior [16]. This method is
effective at troubleshooting problems with the system when the people directly involved
with its development are available to offer their extremely valuable insight. The shortterm benefit with this method is a quick turn-around on anomaly management but it
comes at an increased cost due to staffing the individuals involved. Should these system
experts leave the project, future anomaly management efforts would lack timelines, a
systematic approach, and comprehensiveness in the diagnosis which invariably leads to
increased cost and risk.
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The MBR technique uses a formal knowledge-based and systematic reasoning
framework derived from first principles so that a human operator need not be an expert to
effectively detect and diagnose an anomaly [17]. Though there exists a higher upfront
cost of developing the anomaly manager, the ability for non-experts to make accurate
decisions given a symptom will decrease costs over time.

3.2

MBR Anomaly Management
To address the shortcomings of traditional experiential anomaly management

approaches, significant research has been performed in MBR in an effort to formalize and
manage anomalies as they are encountered in a system. Reasoning conjectures are
computed from fundamental design knowledge which is represented in a system
description. The system description is used to define behaviors of each component in the
system as well as a definition of the connectivity they have with each other. With this
information the performance of the system can be simulated thus allowing predicted
outputs to be generated with the assumption that the system operates nominally.
3.2.1

The Anomaly Management Process
The heart of the AM process (Figure 3.1) lies with its ability to detect, diagnose,

and resolve anomalous behaviors.
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Figure 3.1 – The Anomaly Management Process – Given a set of inputs and
behavioral constraints the real system’s outputs are compared to those of a modeled
representation. The detection process determines whether or not there is a conflict
between the expected and actual values in the outputs. An inconsistency invokes the
diagnosis algorithm which relaxes constraints to attempt to re-simulate the anomaly.
Steps to resolve the anomaly can then be taken based on a list of conjectured diagnoses.
It is important to note that this process can be automated or done manually, and
depending on the system one may be a better solution than the other [1].

To provide further insight into MBR, the three key processes of anomaly management –
detection, diagnosis, and resolution – are defined below. [1, 2, 13, 14, 15, 17]
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Detection: This process is a comparison between actual system data and the
outputs of an evaluated system model. The comparison takes place on the assumption
that the outputs of the simulated system are the expected values. All available data from
both systems including configurations and consistency criteria are inputs for this
algorithm. The consistency criteria are output-specific and may either be checked by
equality or the imposition of an acceptable behavioral bound. If inconsistencies are
found the outputs are flagged as symptomatic and passed to an algorithm responsible for
diagnosing the problem.
Diagnosis: The diagnosis of possible anomalies is found by considering
operational constraints and attributes which are responsible for the behavior in question
to be anomalous. By relaxing or altering these constraints it is possible to place the
modeled representation of the component back into congruence with the real system –
thus appropriately pinpointing the source of an anomaly candidate. Fundamentally
diagnosis can be defined as a systematic process by which constraints and assumptions
are relaxed within a re-evaluated system to match predicted and observed outputs.
Resolution: Given a set of possible diagnoses, anomaly resolution ideally
attempts to restore the real system to its original operating state. If the nature of the
anomaly renders normal operations impossible, the resolution process can strive to
minimize the effects of the anomaly as a best-effort to achieve the primary goals of the
mission.
This research project will assign the resolution process to the operator; thus
placing the ultimate responsibility of taking appropriate action in the hands of a human in
the event of an anomaly. Figure 3.2 shows the anomaly management process illustrated
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as a closed-loop system, where a desired goal or system state is achieved through either
nominal operations or through successful corrective actions.

Figure 3.2 – An Anomaly Management Overview – By representing the anomaly
management process as a closed-loop control system, it can be shown that by
appropriately detecting and diagnosing an inconsistent behavior the operator can restore
expected outputs by manipulating input commands based on desired states, requirements
and constraints [16].
3.2.2

Extended Anomaly Categorization
In the MBR framework employed by Santa Clara University’s Robotic Systems

Laboratory there exists three types of anomalies which can be encountered. Instead of
focusing only on component fault detection, this technique incorporates the use of two
additional conditions, classified as hazards and misconfigurations, to broaden the scope
of possible anomalies [1]. A definition of fault, hazard, and misconfiguration states
follows:
Fault: A fault is a condition given to a behavior which does not match explicitly
that which is described or modeled in the system description. Fundamentally, the output
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of the component is no longer a function of the input as is assumed under normal
operation.
Hazard: A hazard is a behavioral condition that exists when operating in an
unintended state or environment. Typically there are constraints associated with the
operation or use of any component which are given by sources such as a manufacturer or
designer. Though operating under violated constraints, the component may still be
functioning properly and its behavior can still match that of normal operations. For
example, a micro-fluidic valve would be experiencing a hazard if it were operating at 1°C
since the manufacturer has rated the guaranteed normal operation at a temperature range
of 4°C - 49°C. Even though the fluid pumped through the valve has not frozen, the valve
may or may not function appropriately potentially jeopardizing the success of the
satellite’s experiment.
Misconfiguration: This condition exists when the state of a component is not
that which is assumed by the operator. The output behavior is inconsistent based on a
different configuration of component parameters and constraints. This anomaly therefore
not only accounts for operator error or misunderstanding, but in the case of an event
driven system such as PharmaSat, a misconfiguration on the spacecraft could be due to a
design flaw in a preprogrammed set of instructions which would only become apparent in
rare or unexpected cases.

3.3

Modeling Environment
To fully automate and adapt the theories of Model-Based Reasoning, powerful

software tools were needed to appropriately simulate system behaviors as well as to
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generate and store data products efficiently. The selection of an adaptable software
system was necessary for the generation of a custom adaptation of MBR. This software
selection was also driven by previous in-house work so as to build and improve upon
existing knowledge and techniques. [1, 2]

3.3.1 The MATLAB/Simulink Environment
The software chosen to conduct this research work was a computational package
called MATLAB. This is a high-performance programming language and development
environment for technical computing. The package is commonly used for the modeling,
simulation, and analysis of a broad range of engineering systems.
The modeling and processing relied on MATLAB’s embedded block interface of
the Simulink graphical front-end. Simulink offers users the same computational engine
seen in MATLAB but with a graphical interface feature that makes modeling complex
systems more intuitive. Figure 3.3 shows a screenshot of MATLAB’s user interface.

Figure 3.3 – The MATLAB Environment Interface
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The drawback to having selected MATLAB is its computational inefficiency with
regards to slow execution times. The computational package offers a compiler which
may serve as a means of reducing some processing times, however for the purposes of
this research longer processing times were still perfectly acceptable. The MATLAB
development environment and graphical modeling tools more than justify the cut in
performance.

3.3.2

Embedded Block Application
The use of embedded Level 2 M-file S-function blocks in the Simulink

environment was the fundamental implementation tool in this research work. While the
block itself is presented visually to the user, the MATLAB scripting language drives the
block. Within the block a user can specify numbers of inputs and outputs and program
the block to behave in a particular way. Each modeled component had its own
corresponding block whose behavior in code represented to some fidelity the behavior of
the actual component. Some components were modeled on a high level where only
certain behaviors were necessary to be captured for the sake of anomaly management.
Figure 3.4 illustrates a Simulink block and some of its corresponding scripted setup code.
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function diaphragm_pump(block)
% DIAPHRAGM PUMP - NF5-RP DCL 6V -> 50 mL/min
% ASSSUMPTION - No residual volume in the pump
setup(block);
%-------------------- SETUP ----------------------function setup(block)
% SETUP PORTS
block.NumInputPorts
block.NumOutputPorts
% DEFINE INPUT PORT PROPERTIES
block.InputPort(1).Dimensions
block.InputPort(1).DatatypeID
block.InputPort(1).Complexity
'Real';
block.InputPort(1).DirectFeedThrough
false;
block.InputPort(1).SamplingMode

= 2;
= 2;
= 10;
= 0;
=
=
= 0;

Figure 3.4 – A Level 2 M-File S-Function Block and Corresponding Code

The Level-2 M-file S-function defines the properties and behaviors of the customcreated blocks in the Simulink environment. The function supports multiple inputs and
outputs, multi-dimensional input and output signals, a variety of data types, multiple
sample rates, user-defined workspace vectors, and tunable runtime parameters. As will
be discussed in subsequent sections, these features made the modeling of a biological
incubation system possible with enough flexibility to allow the implementation of
anomaly management techniques and algorithms.

3.3.3

MySQL Database Implementation
The MySQL database system is a multithreaded, multi-user application running as

a server which allows for the storage and organization of data. The open-source program
is commonly used for web-applications, and libraries for accessing the MySQL databases
are offered in all major programming languages.
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This research project built on the existing data management system for the ground
operation software used for the GeneSat-1 and PharmaSat missions. As data are
downloaded from the spacecraft, the telemetry is parsed and stored in a corresponding
MySQL mission database. Accessing stored data is possible through a specific
Application Programming Interface (API) in MATLAB. This API is used for the
acquisition of the latest mission telemetry for use in the MBR simulation. Figure 3.5
illustrates the database user interface.

Figure 3.5 – A MySQL PharmaSat Database Instance

3.4

System Modeling Approach
To appropriately model the system a generic approach needed to be implemented

for standardizing the development and integration of individual components. This
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generic approach focused on creating reusable blocks whose modeled behavior was
analogous to their real-world counterparts. The models were constructed so that a nonexpert could efficiently use the system with next to no learning curve.
This section discusses the generic modeling approach and how it was
implemented in the design and creation of the biological payload model used for anomaly
management.

3.4.1

The NewMAAP Approach
The NewMAAP project incorporated the use of MBR on the fluidic propulsion

system based on the Cassini spacecraft as described in Chapter 1 [6]. The modeling of
fluid flow in between actuated components of valves, thrusters, and storage containers is
similar to that used in this research. In the NewMAAP system, components had
specifically defined modes of operation. The transition between modes can be
characterized as either a nominal transition corresponding to an expected behavior or a
failure transition where the behavior of the component is no longer a function of the
command given to it. For example, Figure 3.6 shows the modes and transitions of a valve
and a valve driver.

Figure 3.6 – NewMAAP Transition Systems for a Valve and Valve Driver
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When in nominal operation mode, outflow = inflow which is constrained to equal 1 or 0
for representing fuel flow or lack thereof, respectively. The dynamics are modeled such
that a commanded control input to the valve changes its state from Closed to Open and
vice-versa. Additional modes are Stuck Open and Stuck Closed representing failure
modes which may or may not be resettable.
While the modeled flow is similar, the notion of only explicitly defining two
faults in the system deviates from the framework presented in this research and the AM
technique in general. Using the AM framework, when simulating an anomaly the outputs
of the modeled valves are explicitly undefined; without any form of feedback defining an
exact failure mode for the component is essentially speculation. For example, if a valve
ruptured and leaked, NewMAAP’s Stuck Open or Stuck Closed failure modes would be
insufficient at explaining the anomaly.

3.4.1

The Generic Structure
As discussed in section 3.2.2 the Level-2 M-file S-function was used for the

modeling of all components. The functional representation of a specific component
stemmed from knowledge of the device’s operation. Modeled component behavior was
inherently stated as a function within the block’s script.
The two most common types of data flow in between modeled components were
representations of fluid flow and control signals. The fluid flow was modeled as a vector
containing volumetric flow rate information, concentration of media/antifungal being
pumped, and environmental characteristics such as fluidic and payload temperatures.
Control signals were modeled as required by the specific component. The control input
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for an actuated component was a logical 1 or 0 with the assumption that the
corresponding voltage was sufficient to properly drive the component, since no sensor
data could prove otherwise. Additional control values were used based on specific
component requirements and will be discussed in Section 3.5. The diaphragm pump
model shown in Figure 3.7 offers a good example of the use of all types of data inputs
and subsequent outputs.

High level view

Internal view of modeled component

Figure 3.7 – The Diaphragm Pump Block Subsystem – This image illustrates the
various inputs and outputs common to a modeled component. (a) – A vector representing
fluid flow is depicted here. (b) – The fluid output is modeled here and is a function of
environmental and control inputs. (c) – This is a control vector from the modeled
microcontroller; a vector containing the logical 1 or 0 required for pumping as well as
direction and duration of pumping information. (d) – This flag connects to a telemetry
output in the simulation for the user. (e)/ (f) – These ‘required volume’ vectors allow
downstream components to have upstream effects; for example, pumping to biology from
an upstream media bag.

A required volume data path exists for the sake of modeling a continuous flow.
Within Simulink inputs cannot act as outputs, and vice-versa. To model a bidirectional
behavior an input and output must be defined for each direction of data flow. The
required volume vectors were chosen as a solution to allow components to have upstream
effects, since the modeled biological fluidics system was completely circular. This
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criterion was primarily created for pumps to ‘request’ a volume to be pumped from media
bags located behind them in the fluid stream based on a commanded direction, flow rate,
and duration of pumping. Only pumps are able to actively request media to flow through
the simulation. A demonstration of the fluid flow progression is shown in Figure 3.8.

Figure 3.8 – Modeled Fluid Flow Progression – Based on the pump’s control input a
volume of fluid is requested from (a) to (b). The fluid line passively sends this value from
(c) to (d) where the growth medium reservoir ‘dispenses’ this volume in (e). The fluidic
line then passes the volume back to the pump in (f). Disconnected ports are associated
with other modeled components using the same data protocol.

In order to further manipulate functional blocks the use of MATLAB’s masking
feature was used to edit parameters associated with the given component. These
parameters are an easy way for the user to edit environmental and behavioral values
which affect the output of a component. Figure 3.9 shows the diaphragm pump’s tunable
parameter window.
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Figure 3.9 – Block Parameter Tuning Window – Parameters such as environmental
limits are seen here and can be easily edited by the user. Direct anomaly injection is also
possible with the use of this interface.

3.5

System Models
This section describes three different system models created to help verify the

design of the MBR system. The need to develop a handful of models was driven by the
necessity to test the detection and diagnosis algorithms efficiently as well as to verify
component modeling. Being able to use the same components in three different systems
also demonstrated modularity so as to streamline the development of future biological
payload models for upcoming heritage missions. For an in-depth discussion of specific
component modeling please refer to Appendix A.3.

3.5.1

Simple Model
A simple model (Figure 3.10) was developed so as to verify functionality of the

modeled components used in the biological experiment. The model was run in two
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different cases: as the ideal-case simulated system and as the ‘real’ system in which
anomalies could be injected.

Valve

Valve

Well

Temp/
Growth
Sensors

Pump
Heater
Valve

Media

Controller

Figure 3.10 – The Simple Model – Above: This model incorporated the use of one
media bag, a single path for fluid, one pump, three valves, one well, and a heater. The
components were actuated using a single microcontroller model. Both real and
simulated cases were run using this model which allowed for direct comparisons.
Below: a high level diagram shows the connections in the Simulink model above.
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Running both ideal and anomalous cases in parallel offered a way of developing
techniques to detect and diagnose anomalies in an environment with reduced
complexities. This also enabled verification of each component’s expected operation.
The system implemented the use of a modified microcontroller model which was
responsible for actuating a diaphragm pump, three valves (both A and B-type), and heater
actuation to set the well plate card temperature. There were a total of three phases
modeled in this system; two recirculation phases (non-heated and heated fluidics) and a
growth media delivery phase to the biology. Additional components used for simulating
the experiment were fluidic lines as well as growth media and waste bags.
For simplicity only one biological well was modeled. The well model was
adjusted to emulate the biological growth behavior seen in the GeneSat-1 mission
telemetry. Simple environmental factors including well temperature, growth media,
relative humidity, and air pressure enabled growth when within pre-determined (nominal)
bounds. These values did not necessarily need to represent reality; rather they were
placeholders for more complex models discussed later in this section. The equations and
logic describing the simulated behavior are shown below.
If

Else

Growth Media = 0 counts AND Temperature ≠ 0 °C AND
Pressure ≠ 0 psi AND Relative Humidity ≠ 0 %
Bio(t) = L0
If Growth Media > 0 counts AND Temperature ≠ 0 °C AND
Pressure ≠ 0 psi AND Relative Humidity ≠ 0 %
Bio(t) = L0 + G *log(max(1, t- t3))

[3.1]

Else
Bio(t) = undefined
Equation 3.1 – Simple Biological Model – L0 is the initial count level, G is the growth
constant, t is experiment time, and t3 is the time at phase 3. Specific environmental
conditions and media feeding enabled growth in the well. Outside of these expected
conditions modeled growth was not permitted. Any environmental anomalies would be
expressed as a 0 in this simple model.
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For the Simple Model L0 was set to 0 and was used as a placeholder for more
complex models. T3 was simply the elapsed simulation time up to Phase III where
growth could begin. The log function is a simple logarithmic MATLAB operation whose
output closely resembled that of GeneSat-1 data. Lastly, the growth factor G was set to
1.5 and was used as a placeholder for future biological models which would incorporate
the use of stunted growth due to antifungal agents. The violations of any imposed bounds
would lead to an undefined growth behavior represented by MATLAB’s Inf value.
Figure 3.11 shows nominal growth of simulated biology compared to GeneSat-1 data.
Simple Model: Well 1 Telemetry
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Figure 3.11 – Simple Model Biology – Nominal growth for the Simple Model (left) was
modeled on GeneSat-1 optical density data (right) after a growth media signal was
received by the well block and when environmental conditions such as pressure,
humidity, and temperature were simply non-zero. Placing more restrictive environmental
bounds was to be done in subsequent models with increased complexity.

The state of the well was monitored by two simulated sensors for optics and
temperature. Explicitly modeling sensors in the system allows perceived anomalous
behavior to be also likened to faulty sensing. The sensors themselves do not have any
modeled error based on the assumption that the real components’ errors are too small to
cause a measured anomaly. Sensor outputs are written to text files for both ‘ideal’ and
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‘real’ cases from where the detection script can pull and compare values. Results from
the use of this system are discussed in Chapter 4.

3.5.2

Biological Prototype
The biological prototype was created to generate real telemetry pertaining to the

execution of an autonomous biological experiment similar to that of the PharmaSat
mission. The system model shown in Figure 3.12 shows the modeled biological
prototype. Appendix A.2 shows an enhanced version of this graphic.

Figure 3.12 – Biological Prototype Model

53

Diaphragm Pump
Well Plate
Filters

Connectors

Tubing
Media Bag

1

2

Valves

Waste Bag

3

Check Valves

4

Figure 3.13 – Biological Prototype Layout

The same function blocks that were used in the Simple and PharmaSat models
were also used to create this system description. As with the real system (outlined in
Figure 3.13 and described in Section 2.3), this graphical model incorporated the use of
one diaphragm pump, four 3-way valves, one heater, four temperature sensors, six optical
detectors for six biology wells, a growth media bag, waste bag, and fluidic lines
connecting the appropriate components. The two microcontrollers on the real system
were modeled as one block for simplicity. Simulated telemetry was compiled and written
to a text file in the root folder. A detailed outline of all experimental phases is shown in
Appendix A.2.
Repeated ‘ideal case’ testing in the actual prototype helped evaluate the biology’s
behavior over time thus allowing for the creation of a reasonably accurate mathematical
description of growth. A simulated well allowed its analog/digital (A/D) count variable
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to change according to a simple linear equation when a growth media signal was received
and environmental conditions were in acceptable bounds. In the event of multiple growth
media dosings (as was the case with the prototype model) the A/D counter would
increment a fixed amount for each time the media was administered. As with the real
system, more feeding increased overall growth registered by a higher aggregate change in
A/D counts. This was desirable because the resulting regression curve fit would contain
a significantly higher slope, whose value was the metric used to determine a well’s
health. The role of regression curve fits and their slopes will be further discussed in
Section 3.6.1. The logic and equations used to generate the simulated biological growth
are described below.
If
Else

Growth Media = 0 counts AND Temperature ≥ low_temp_threshold
Bio(t) = L0
[3.2]
If Growth Media > 0 counts AND Temperature ≥ low_temp_threshold
Bio(t) = L0 – G * max(0, min(100, t- t3)) – G * max(0, min(100, t- t7))

Else
Bio(t) = undefined

Equation 3.2 – Biological Prototype Growth Model – L0 is the initial count level, G is
the growth constant, t is experiment time, t3 and t7 are the times at phases 3 and 7,
respectively. Given an adequate environment and a growth media signal the well’s
growth equations were enabled. Pressure and humidity were not included due to the
experiment being performed in a laboratory.
For this model the variable L0 was set to 10 A/D counts based on initial readings
from the real system. Once simulated growth media was delivered to the well and the
temperature was above the low_temp_threshold of 20 °C the A/D counts decreased with a
linear slope of -0.3 counts/sim-step which was defined by the growth constant G. The
aggregate A/D value was re-evaluated each simulation step and capped at 100 steps. This
process was performed twice given the two media dosings resulting in a greater overall
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drop in A/D counts signifying more growth. As with the other models developed in this
research project, it is important to note that modeling a general behavior would suffice.
For example, the time duration of the real and simulated systems did not have to match so
long as the general behavior was analogous. In this case the curve fit needed to have
similar properties for the detection algorithm to consider the two models analogous. A
decreasing exponential curve from a single dosing would have likely provided a better
fidelity model, though either approach was sufficient. Figure 3.14 compares the
telemetry generated from the real system compared to that of the simulation.

Figure 3.14 – Real vs. Simulated Growth – As more yeast grew in the well, the amount
of transmitted light decreased. The plot on the left shows this behavior from the real
system while the simulated behavior is shown on the right. It is worth noting that A/D
counts are decreasing due to the sensing employed in this experiment. Other systems
described in this chapter show increasing counts.
The experiment was modeled on a phase-by-phase basis rather than a continuous
time-based approach. This meant that while each phase had an expected behavior, the
simulated duration of a given phase did not necessarily correlate to that of the actual
system. There was no need to simulate phases that lasted for hours as long as the
behavior of that phase was modeled appropriately. It was empirically determined that 70
simulation steps were adequate to model the behavior of each phase. A block which
processes an input and returns a valid output takes one step. This makes the total number
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of steps in a phase a function of the number of components in the system. An additional
margin was imposed so as to aid the user by allowing time between phases for visual
reference in the graphical interface. Even with this margin included, the total time to a
complete simulation for the 70 hour prototype experiment was approximately 27 seconds.
Each simulation step generated its own string of telemetry which was written to a
text file. The format of this output string is shown below:
output = [phase, clock, B1, B2, B3, B4, P1_dir, duration_on,
card_set_point, card_heat, card_heat_stability, optical_condition,
experiment_armed_state, temp_1, temp_2, temp_3, temp_4, temp_avg,
optics_1, upper_bound_1, lower_bound_1, optics_2, upper_bound_2,
lower_bound_2, optics_3, upper_bound_3, lower_bound_3, optics_4,
upper_bound_4, lower_bound_4, optics_5, upper_bound_5, lower_bound_5,
optics_6, upper_bound_6, lower_bound_6];

Figure 3.15 – Simulation Output String

The data string provided information about the current state of the system
including phases, pump and valve states, temperatures, and optical readings.
Additionally, optical bounding conditions were physically modeled. These provided two
‘worst case’ scenarios for each phase in between which the actual biological growth
measurement was permitted to be without being flagged as anomalous. Due to the nature
of the prototype system, these bounding conditions were relatively loose given the
inherent noise in the sensing and were not immediately used in the detection process.
Results from the use of this system to detect and diagnose anomalies in the real test bed
are presented in Chapter 4.
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3.5.3

PharmaSat Model
The high fidelity model used for PharmaSat implementation is presented here

along with techniques and pitfalls of modeling such a complex system. A total of 175
components were modeled including fluidic components, biological samples, and sensors
for telemetry generation. Figure 3.16 shows the entire payload model as developed in
Simulink. For a higher detail figure and fluidic diagram please refer to Appendix A.1.

Figure 3.16 – PharmaSat Payload Model

Model blocks used in this system were identical to those discussed in the previous
two sections. The addition of a stepper pump model, check valve, antifungal bag,
dilution bag, additional waste reservoirs, fluidics heater, 3-way valves connected in
reverse, tri-color LEDS for biological colorimetry, and corresponding optical sensors
were the biggest changes to the model besides the combined quantity of all components.
All 12 phases of the experiment were modeled here including 51 sub phases
resulting in 111 unique steps. These phases are outlined in Appendix A.T.1. The file
expected_values.m physically stored each step which the simulation used as a reference.
A separate file eased editing entries through the development of not only the model, but
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the satellite as well. For example, the PharmaSat payload underwent a calibration
procedure in which the exact number of steps the pump is commanded to run at changes
between flight units. This is due to uneven fluidic line lengths and other small hold-up
volumes in the pumps and valves which may affect antifungal concentrations. After
testing was completed these calibrated pump values were easily substituted into the file.
The microcontroller model block executes a function call at the start of the
simulation which loads all entries from expected_values.m into memory, then
sequentially executes each step throughout the experiment. Upon actuating the
appropriate pumps, valves, and heaters the controller also outputs its current state to a
telemetry logging block. Recording each experiment state is essential for checking the
configuration of the experiment on the spacecraft. Though states were preprogrammed
on the spacecraft (much like in the simulation), occasionally in testing unanticipated
configurations would produce anomalies; checking for these in flight was imperative.
Payload environmental elements are modeled as well. Temperatures are actively
controlled through the well plate and fluidics heaters. An assumption in the modeled
system is that the set point of a heater is in fact the temperature of the component(s) it is
heating. The modeled temperature sensors consequently output this set point temperature
which is used for fault and hazard checking.
The relative humidity and air pressure are both passive in the payload and
therefore constant in the simulation. Bounds are imposed on the real system’s telemetry
when compared to these ideal values. The simulation’s ideal pressure and humidity
values were updated upon the final loading of the payload before launch when the
canister was sealed.
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Lastly, the payload’s modeled biology offered unique ‘ideal case’ behaviors
which provided predictions as to how the real biology would grow. These models were
in essence no more complex than those used in the prototype and simple models
discussed above; however the mathematical description of their dosing and growth was
chosen to exhibit the behaviors which were relevant to determining the state of health of
the real experiment. These characteristics included a change in light intensity after
growth media dosing D, a growth constant G which would attenuate or accelerate the
growth of the simulated biology based on how much antifungal was predicted to be
present, and a lack of any of these behaviors if the modeled environment or fluidic
system was in an anomalous state. As with the real unit, each simulated well produced
data for red, green, and blue channels. In the case of the PharmaSat experiment, it was
perfectly acceptable to leave the equations identical for all three color channels in a given
well because they all exhibited similar behaviors in the real system. The logical
constraints and subsequent equations for the model are summarized below:
If

Else

Growth Media = 0 counts AND Temperature ≥ 5 °C AND
Pressure = 14.25 ± 1.25 psi AND Relative humidity = 65 ± 25%
Bio(t) = L0
If Growth Media > 0 counts AND Temperature = 27 ± 2 °C AND
Pressure = 14.25 ± 1.25 psi AND Relative Humidity = 65 ± 25%
Bio(t) = L0 – D + G * log(max(1, t-t3))

[3.3]

Else
Bio(t) = undefined

Equation 3.3 – PharmaSat Well Growth Model – L0 is the initial count level, D is the
drop in counts after media dosing, G is the growth constant, t is experiment time, and t3 is
the experiment time elapsed at phase 3. Though the model includes more stringent
environmental considerations, its overall structure is similar to that of more basic models
described earlier in this section.
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Figure 3.17 shows a typical output from all three simulated color channels. The variation
in growth performance is dictated by the growth constant G from Equation 3.3.
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Figure 3.17 – Simulated Optical Measurements – A typical output is shown for a
simulated color channel showing the biological growth model after the entire experiment
duration. Note the change in growth performance given different growth constant values.
The biological models described in this section provided a defined growth behavior
only when all environmental parameters were known to be within certain bounds.
Outside of these pre-determined bounds the behavior of the biology was not guaranteed
to be predictable; therefore the simulation made no attempt to predict such outcomes.
The real biology could perhaps grow in unknown conditions however there existed no
data for these permutations. Its growth would be described as “anomalous,” meaning
having occurred outside of a pre-defined envelope of constraints. This is significant with
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regards to the experiment’s outcome since its premise involved the removal of all
variability except microgravity between ground and flight units. More insight on the
characterization of biological growth behaviors is offered next.

3.6 Applied Anomaly Management
This section revisits the anomaly management algorithms discussed in Section 3.1
and presents how they were implemented in MATLAB and applied to the models
illustrated in Section 3.5. The functions accessed data produced by the real and simulated
systems and were capable of manipulating the models in the event of a detected anomaly.
The experiment carried out on the PharmaSat mission was designed to be
autonomous with limited human intervention. The experimental data products created by
the spacecraft were downloaded by mission operators and could potentially be freshly
recorded or weeks old. Additionally the nature of these downlinks would be such that no
immediate resolving action would be taken since the operators were engaged in
downloading as much data as possible in a very short window (approximately 10 minutes
per contact). Consequently, this decision support tool did not need to act exactly in real
time and near-real time performance with short processing times was acceptable.
Existing data that had been downloaded from the spacecraft, including new data just after
the contact, could be processed and anomalies could be detected and diagnosed. Once
this type of decision support tool was implemented in the ground segment for a
spacecraft, it could aid mission operators in planning the next set of commands as the
spacecraft orbited back around for another contact.
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3.6.1

Detection Algorithm
The detection algorithm was implemented in a MATLAB function and used a

system of comparisons to check for consistency between real and simulated telemetry
with the assumption that a deviation indicated an anomalous symptom. The system
model is run initially with a nominal configuration to generate the real system’s predicted
values.
Upon generation of these predicted values, the system is checked for consistency
using the detection.m function. Specifically, the following checks are made:
•

Any values that are part of the spacecraft’s event-driven state machine are
checked with predicted values. For example, such consistency checks are
performed for telemetry regarding pump states, valve states, and various
conditions such as optical, thermal, and experimental arming that need to be met
before the next phase of the experiment is allowed to proceed. Inconsistencies
with these comparisons are found by inspection and reported to the user as a
possible misconfiguration.

•

Telemetry values that are found to be inconsistent with pre-determined constraint
bounds (including parameters involving environmental conditions) are found by
inspection and reported to the user as a possible hazard.

•

Lastly, growth behaviors are compared for real and simulated systems. The
biological growth is the best sensor for the state-of-health of the payload. Should
there be a measured discrepancy between the two, it is indicative of a wide variety

63

of possibilities which are not directly observable. The constraint relaxation
technique is therefore invoked to diagnose the anomaly.
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Figure 3.18 – Detection Algorithm – Once telemetry is downloaded from the spacecraft
predicted values are generated and a series of checks are performed [1]. If there are
inconsistencies symptoms are appended to a list thus invoking the diagnosis algorithm.

It is important to note that the first two checks in the detection algorithm produce
symptoms and a direct diagnosis to the user. In these cases, the anomalies are presumed
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to be directly oberservable and are reported as such. The symptoms found by the third
check are not caused by immediately observable behaviors and require the constraint
relaxation technique discussed in the following section for making diagnosis conjectures.
A portion of the detection algorithm involved the behavioral characterization of
the onboard biology. Though biological growth will never be completely repeatable,
significant resources had been expended by the PharmaSat team to minimize variations
between experiments. This offered a well-characterized behavior that could be abstracted
and interpreted autonomously on a high level. As the premise of the experiment would
suggest, with all variables kept constant, the variation between ground and flight
experimental growth may be attributed to microgravity. However, with external
variables not kept constant, biological growth can vary significantly from expected
behavior. Given that this research focused on payload state-of-health, variables of
interest were hardware health and environmental attributes (temperature, pressure, and
humidity). Problems with biocompatibility or effects from microgravity, among many
other variables, were not considered.
To better interpret the behavior of the biology in the PharmaSat experiment, three
measurements were performed on both simulated and real data sets for each well’s red,
green, or blue color channel. The results of each of those measurements, when
considered together, indicated the health of the biological well. By setting definitive
thresholds to these measurements, a quantitative characterization could be derived from
an otherwise subjective assessment that a satellite operator would have to make.
The thresholds were determined empirically by analyzing available data from
both ground experiments and in flight. After calculating the appropriate metrics for all
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available wells, defining minimum criteria for growth required expert opinion. Wells that
exhibited minimal growth behaviors were therefore used as the benchmark. After a small
safety factor was incorporated to lower the minimum criteria slightly, a performance
envelope was effectively created. Those wells whose measured characteristics fell
outside of this envelope did not grow any biology. Table 3.1 shows selected thresholds
for both real and simulated cases. A discussion follows which details each threshold
criterion.

Detection Threshold
Criteria
Real Wells
Simulated Wells

Dose Drop
(counts)
9000
2

Maximum Slope
(counts/sec)
± 0.4
± 10-5

Absolute Change
(counts)
1000
50

Table 3.1 – Experimental Detection Thresholds – These thresholds were determined
empirically by evaluating available data from ground, flight, and simulated experiments.
Though initial evaluations required the opinion of an expert, once implemented, any user
could make assertions regarding growth assuming the envelope was defined accurately.

The first measurement involves finding whether or not a well has been dosed with
growth media early in the experiment. This dosing has a distinct behavior in that the
optical intensity readings of all three color channels drop a significant amount in a very
short period of time. This is an indication of growth media infused with Alamar Blue
being pumped into a well which was optically clear and full of de-ionized water. The
change in light transmittance is therefore an indication of healthy upstream fluidic
components which delivered growth media to the intended target. This case is shown in
Figure 3.19.
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Figure 3.19 – Dosed Well Example – The drop in measured light intensity produces a
quantifiable behavior in both real (left) and simulated data. Dosing criteria is evaluated
individually on each color channel in the two systems. The threshold for the real data is
set to 9000 counts/ 2 hours. The simulated threshold is 1000 counts observed
instantaneously.
After growth media dosing (or lack thereof) is identified, the next measurement
involves the interpretation of biological growth. As is the case with many biological
specimens, a yeast population’s rate of growth is directly proportional to its overall
health. Therefore the method chosen for abstracting and interpreting the biological
growth is based on the derivatives of statistical regression curves. By fitting a
polynomial trend line a continuous mathematical approximation can be made on discrete
experimental data points. In regards to this research, the best use of the trend line is not
in absolute values but in changes in slope. A variation in slope above a defined threshold
indicates a rapid change in growth behaviors or experiment state. This assessment may
or may not be desirable and depends on where it was observed. For example, a well in a
freshly dosed bank with no antifungal would presumably have a measured growth event
with a rapidly changing slope. A reference well which never saw any growth media
would be flagged as symptomatic based on there being detected growth where none was
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expected. Figure 3.20 shows an example where growth is detected after successful
dosing of a well, for both real and simulated cases.
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Figure 3.20 – Detected Growth – Cases (a) and (b) show a rapidly changing slope after
dosing which indicates growth. Plots (c) and (d) offer a quantitative measurement of the
quality of growth from these wells. A well whose slope is found to be over the set
threshold (±0.5 counts/sec for both real and simulated data) is therefore considered to be
actively growing.

The final measurement involves finding the absolute change in intensity values
after a dosing event has been detected. This is an especially important measurement for
wells which offer highly stunted growth or no growth at all. In these cases the change of
slope necessary to evaluate growth quality is small enough to either fall under the
threshold or not be discernable from noise inherent in the curve fitting process.
Measuring the absolute change in light intensity for each well’s color channel (simulated
68

or real) offers another way of determining whether or not a change has occurred over
time. Specifically, this measurement is made by subtracting the minimum intensity found
from the maximum so as to negate any ripple from either the biology or the sensor.
Figure 3.21 illustrates the nature of this measurement for both real and simulated
telemetry.

Figure 3.21 – Absolute Measured Intensity Change – For each color channel in a
given well, the minimum measured value is subtracted from the maximum and compared
to a predetermined threshold. The maxima and minima for both real and simulated data
are illustrated by a magenta line. The threshold was set for 5000 counts in the real data
and 400 counts for simulated data.

Based on these three measurements, a wide variety of cases could be evaluated for
both nominal and off-nominal scenarios relating to PharmaSat’s biology. An unfed well
with no growth would exhibit a flat lined behavior, resulting in no detected changes to the
light intensities throughout the experiment. Figure 3.22 illustrates this type of behavior.
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(c) – Real Data Slopes
Figure 3.22 – Modeled vs. Real Undosed Well – Without a dosing of growth media
there is no significant drop in light intensity. Even a temperature-induced fluctuation
seen in (a)’s red channel is not sufficient to go above the threshold. However, this
fluctuation creates noise in the slope calculation (c), even though it is generally under the
threshold. The simulated data in (b) by inspection has a slope equal to 0.

In the event of dosing but no growth, such as what is seen in the high
concentration wells, one of the three measurements is found to be true. Slope
measurements and absolute values of growth remain near zero after the dosing threshold
is exceeded. Figure 3.23 illustrates this case.
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Figure 3.23 – Modeled vs. Real Dosed Well With No Growth – The fluidics network
successfully delivered growth media to the biological well but no growth was measured
in any of the color channels. This leads to near-zero slopes and no significant change in
light intensity after initial dosing.

When a medium concentration of antifungal is applied to the biology, some
growth is typically visible; however it appears to be very limited. In this case it is
important to measure the dosing and any net change over time. Attempting to measure
the slope alone will likely be unsuccessful because of how slow the growth progresses in
the experiment. Slow growth and small slopes land under the detection threshold and are
therefore not considered in this case. Figure 3.24 describes this scenario.
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Figure 3.24 – Modeled vs. Real Dosed Well With Some Growth – Stunted growth is
visible due to the higher dose of antifungal. In this case the slope becomes difficult to
measure and is ignored. It is more accurate to detect dosing outright and measure a
cumulative change in light intensity over the experiment duration.

Low concentrations of antifungal lead to only slightly stunted growth which will
nominally exceed all three thresholds (dose, net change, and slope) for both simulated
and real data. Figure 3.25 shows this case.
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Figure 3.25 – Modeled vs. Real Dosed Well With Acceptable Growth – This case
offers a look at successful dosing for all three channels, rapid changes in slope, and
overall growth after dosing. Growth is slightly stunted (as expected) due to the low
concentration of antifungal in this bank.

Lastly, the 12 wells in the control bank never saw antifungal and thus enjoyed
unrestricted growth. While the dosing behavior remained the same as all other wells,
measured slopes and net changes in intensity were both the highest in the experiment.
All three thresholds for each color channel were exceeded thus indicating a completely
healthy well. Figure 3.26 provides a typical example.
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Figure 3.26 – Modeled vs. Real Dosed Well With Unrestricted Growth – This case
shows dosing, crisp slopes, and ample changes in intensity indicating on all levels that
both the real and simulated wells are completely healthy.

The lack of substantial sensing in the PharmaSat payload and the general fragility of
biological samples made the measured growth behaviors the best ‘sensor’ for the
spacecraft’s state of health. It was therefore important to classify these behaviors in a
manner which would quantitatively indicate the state of the experiment to a fairly high
degree of precision with a quick turn-around.
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10000

3.6.2

Diagnosis Algorithm
Upon a compilation of symptoms from the detection script, the diagnosis

algorithm outputs components which have possibly caused the erroneous behavior. All
symptoms are initially passed to the operator before the diagnosis algorithm is invoked.
Anomalies must lie upstream from where the symptom was found. Therefore for
each symptom a list of upstream constraints is generated, including behaviors, operating
conditions, and configuration statements. Commonly there exist multiple symptoms for
only one anomaly which necessitates multiple upstream component lists. The
intersection of these lists is the set of upstream components that are common to each
symptom and therefore represent the candidate list.
Having compiled the final component list the diagnosis algorithm sequentially
forces each model block into an undefined state by manipulating the fault_flag of the
block. For each candidate, the experiment is simulated with the component’s operational
constraints relaxed. With the anomaly simulated, the resulting telemetry is once again
compared to the observed values of the real system using the same detection algorithm.
If no symptoms are found the anomaly was successfully simulated and the component
under evaluation is added to a candidate list. The component is then forced back into a
nominal state and the next component on the upstream is evaluated. A flow chart of the
diagnosis algorithm is illustrated in Figure 3.27.
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Figure 3.27 – Diagnosis Algorithm – Given symptoms, constraints are relaxed, the
system is re-evaluated, and candidate anomalous components are displayed [1].
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3.7

Chapter Summary
This chapter illustrated the fundamental theory behind Model-Based Reasoning

and showed how this theory was applied to a real-world engineering system. The use of
a graphical modeling environment allowed the creation of system descriptions unique to
biological incubation payloads for anomaly management. More specifically it was
necessary to capture constraints and behaviors unique to the PharmaSat payload in the
system model thus necessitating experiments of varying complexity to verify proper
operation of this decision support tool. The same model components were created and
reused in three experiments; all of which incorporated identical algorithms for detection
and diagnosis conjectures in the event of an anomaly. This also demonstrated modularity
between systems and adaptability not only for the PharmaSat experiment, but future
heritage missions involving biological payloads.
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4. Experimental Results
The application of Model-Based Reasoning techniques to a biological system was
validated through a series of experiments before testing with the payload of the
PharmaSat spacecraft after its launch. This chapter discusses such testing scenarios and
presents results pertaining to the injection of anomalies as well as unplanned component
failures in preparation for PharmaSat mission operations. Lastly, results from testing
with the spacecraft in orbit are presented. These results validate the approach used and
demonstrate the decision support tool’s speed and accuracy for use in on-orbit mission
operations.

4.1

Observability
A telemetry snapshot of the spacecraft’s payload state is logged every 8 minutes.

This snapshot offers a glimpse into the health and status of the spacecraft over the
mission lifetime. While the data’s resolution is perfectly adequate for deducing
anomalies over time, it is not logged quickly enough to guarantee feedback on critical
events. These events are namely the repeated actuation of pumps and valves in the
fluidics network; an essential part of the experiment execution. For example, feedback of
these events could be measured by a brief spike in current draw upon expected actuation.
A more novel solution proposed early in the design involved listening for actuation by
use of a small microphone. Not having immediate critical event feedback is still
acceptable in a high-risk low-cost mission. Therefore, the best critical event sensing that
the anomaly manager could take advantage of was the biological growth itself.
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This system also included numerous components strung together serially.
Without a means of probing for sensing in between concatenated components, often
times a single point of failure can only produce an ‘everything upstream’ candidate list
since there is no information to suggest otherwise.
Acknowledging these limitations, the anomaly manager is still able to quickly
detect an anomalous condition and within minutes offer a possibility as to what may have
gone wrong with the spacecraft’s payload. This capability is still a great asset to any
mission operations team. Without it, operators would need to possess expert knowledge
of a complex system to meticulously analyze telemetry and make conjectures while
adequately informing mission management of the situation.

4.2

The Simple Model
To first validate the algorithms used in this system a simple model was created

using existing component blocks. This model acted as a test bed with reduced
complexities and offered a means to troubleshoot while the tool was in the development
phase. Two identical models were executed: one acting as the observed (‘real’) system
and the other acting as the ideal case simulation. Anomalies were injected into the
observed system and were later diagnosed using the simulated case.

4.2.1

Modeled Valve Failure
Though the valves used on the PharmaSat system were flight qualified, their small

size, relatively fragile nature, and immediate importance to the successful execution of
the experiment made them a good candidate for checking fault detection and diagnosis
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algorithms. Since there is no direct feedback as to whether or not a valve has operated
nominally on the spacecraft, a candidate fault condition can only be inferred by
simulating a failure and analyzing the results.
In the model acting as the real system, Valve B-1 was forced closed to simulate an
outright malfunction. The model then ran through the entire experiment generating
telemetry that would be checked by the detection algorithm. Figure 4.1 shows a plot of
generated telemetry of the two simulations each having executed once.
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Figure 4.1 – Predicted vs. Observed Model Telemetry - All telemetry is included in
one plot. If the system was healthy note that all values would completely overlap.
However, a flat line is observed with the ‘real’ yeast, indicating no growth.
Growth metrics were compared for both the simulation and real models and a symptom
was found. The real yeast was found to be out of expected bounds with no change in
regression curve fit slope. This generated a symptom which invoked the diagnosis
algorithm thus evaluating all logical upstream components. The symptom originated
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from the first point of sensing, in this case the optical sensor which measures growth. A
list of diagnosis conjectures is shown after the algorithm was invoked.

Figure 4.2 – Simple Model Diagnosis Output – After detecting a symptom, it is
observed that all fluidic components upstream from the growth media bag (GM) are
anomaly candidates due to the serial component connections. Nevertheless,
environmental components are not considered, and no hazards or misconfigurations
were found; a good initial test of the algorithms. These candidates (including the faulted
Valve B-1) were identified in less than 3 minutes. This marked an excellent first step
which validated the desired approach for this research project using a simple model.
The generation of a handful of candidate components in the fluidic network in of itself is
not necessarily interesting since this system’s observability is limited. However for the
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testing of model execution, configuration criteria, and constraint descriptions, the result
was a positive step forward in diagnosing anomalies based on the behavior of a biological
sample. Figure 4.3 shows part of the simulation running as each component’s constraints
are individually relaxed.

Figure 4.3 – Valve B-1 Induced Fault State – Valve B1 was forced to an ‘off’ position
to simulate a fault. This caused the fluid signal to bypass the well and circulate back
through the modeled fluidic system. Evidence of the well’s lack of growth is indicated by
the two 0 values, one for fluid signal and one for corresponding growth.

4.2.2

Modeled Heater Failure
The payload heater is required to incubate the biology samples and maintain them

at a constant temperature to maintain experimental accuracy. As seen after the primary
experiment was completed on the GeneSat-1 mission [21], a failed well plate heater will
cause large temperature swings on the payload card as the spacecraft transitions from
sunlight to eclipse and back. For the purposes of this model, ambient temperatures are
set as an adjustable constant and typically lower than the set point of the heater controller.
The thermal model is basic; for example, losses due to heat transfer are not considered.
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When a simulated heater failure occurred, the temperature of the well plate
dropped significantly thus retarding the growth of the biology. Some growth is still
visible (Figure 4.4) since the sample was successfully dosed with growth media.
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Figure 4.4 – Modeled Well Plate Heater Failure – Real biology growth (black) is
visibly slowed compared to the predicted case (yellow). The anomaly manager detected
growth that was out of acceptable bounds, but after curve fitting and applying a slope
threshold it was determined that some growth had occurred, likening a temperature
related anomaly over that of the fluidics network.
Since some growth was detected and the temperature was inconsistent, the symptom
originated at the temperature sensor as opposed to the optical sensor. The upstream list
compiled therefore included the temperature sensor, biology sample, and heater. Figure
4.5 shows the output given to the user once the diagnosis algorithm had relaxed
constraints in each case.
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Figure 4.5 – Simple Model Diagnosis Output – The anomaly was detected at the
temperature sensor and diagnosed to be the heater in less than 1 minute.
Though the temperature sensor is where the symptom was originally detected, the
diagnosis algorithm only returned the heater as an anomalous candidate. This logically
makes sense; had only the temperature sensor failed the biology’s growth would have
remained unaffected. Had the well itself failed no growth would have been seen at all.
Therefore the only remaining candidate in the upstream list had to affect both
temperature and growth and by faulting the heater the correct symptomatic behavior was
exhibited. As a sanity check, the failed temperature sensor case in shown in Figure 4.6.
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Figure 4.6 – Simple Model Failed Temperature Sensor Case
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4.3

Biological Prototype
Once the approach and algorithms were verified on the Simple Model, the added

complexity of the biological prototype was introduced for hardware-in-the-loop
verification. The experiment was designed to exhibit as many similar characteristics to
PharmaSat as possible so that the anomaly management process could be refined before
the satellite’s launch. The fluidic components and yeast strains used were identical to
those of the flight unit. Growth media, heaters, sensors, and supporting circuitry were
closely analogous. The test bed is discussed in detail in section 2.3 and a close up photo
is shown in Figure 4.7. The experiment generated the same telemetry format as the
simulated model making integration into the anomaly management system relatively
straightforward.

Figure 4.7 – Biological Prototype Test Bed – The 6-well plate is located to the left
along with a suite of 1.2 µm syringe filters, heat spreader plates, and optics sensors. The
well plate cover is in the foreground along with growth media and the diaphragm pump.
Valves are located in the middle and supporting electronics are to the right. A laptop
(not pictured) continuously logged telemetry for the experiment’s duration.
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Though the fidelity of the test bed was not that of a precise biological growth
instrument such as the spacecraft itself, the data required for testing was generated in a
low-cost yet still effective manner. For example system noise was always a concern
when analyzing experimental data, however mitigating these problems in the prototype
provided valuable lessons learned in preparation for the on-orbit case.
Execution of the entire hardware experiment was on the order of 72 hours;
comparable to PharmaSat’s 96 hour duration. The criteria for the optical sensors were to
simply detect whether or not a well exhibited growth behavior. This was made possible
by reading an analog to digital (A/D) value produced by each well’s corresponding
photodiode. Since the changes of these values is subtle as the turbidity of the well
increased over many hours, occasionally fluctuating values due to voltage noise could
potentially tamper with actual growth data. However seeing a downward trend in light
levels over the course of the experiment was sufficient to detect growth (as the cell
population grew less light was let through to the photodiode). To smooth the data the
same curve fitting approach was used as previously discussed and a negative slope
threshold was applied for growth determination. The exact threshold value was
experimentally determined after having run the experiment several times.
Three experimental runs were executed with separately induced anomalies for
each case. At the conclusion of these experiments, the gathered telemetry was passed
through the detection and diagnosis algorithms to validate their operation with real
hardware. The results from these tested cases are presented in this section.
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4.3.1

Valve B-2 Failure
The frail nature of the valves used for the flight unit make them good candidates

for anomaly validation as seen in this test case. The pre-experiment failure of the B-2
valve on the test bed was in fact unintentional and likely occurred during sterilization of
the fluidic lines or the loading of the biology into the well plates. As the experiment was
run it was observed that the B-2 valve did not actuate when required by the state
machine. Growth media was pumped through the inactive port in the valve and into the
waste bag, leaving wells 3 and 4 undosed and the cells sitting in the de-ionized water they
originally started the experiment in. Testing of the valve after the experiment concluded
that a lead had been broken internally thus irreparably damaging the valve. Telemetry
gathered from the experiment is shown in Figure 4.8. A diagram illustrating the anomaly
is presented in Figure 4.9.
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Figure 4.8 – Experimental Results for Faulted Valve Condition – 72 hour
transmittance plots are shown for each well. Each red line is the fitted regression curve
used for growth detection. Note the flat lines of wells 3 and 4 indicating no growth.
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Figure 4.9 – Valve B-2 Failure – Optical sensors 3 and 4 were flagged as symptomatic
when no growth was detected in their respective wells. Constraint relaxation of upstream
components found only one that could be responsible for wells 3 and 4 to have no growth
conditions. The next upstream component is a fluidic line which must have remained
healthy since wells 5 and 6 were adequately dosed with media.

The recorded temperature telemetry (Figure 4.10) for this experiment was within bounds
and consequently did not get flagged as hazardous or faulted. Additionally, the
configuration of the predicted system model and hardware test bed were consistent
indicating that the each phase of the experiment had been executed as expected.
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Figure 4.10 – Nominal Temperature Data – Through the first two phases of the
experiment as the heater began to warm the sample, temperature constraints were far
less stringent (± 15°F). Once the set point temperature was reached and maintained,
these constraints were narrowed to ± 5°F.
Passing the experimental telemetry through the anomaly manager generated the
output shown in Figure 4.11. Due to the increased complexity of the model, simulation
execution time for each candidate anomalous component was approximately 34 seconds.
With a large upstream component list for each symptom there could potentially be a 1020 minute wait before the anomaly manager returned any results. Future work should
focus on bringing this processing time down by generating a shorter upstream component
list.
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Detection Output

Diagnosis Output

Figure 4.11 – Detection and Diagnosis Output, Faulted Valve Case
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The faulted B-2 valve was returned as the only possible candidate after
approximately 16 minutes of processing time. In this example the failure of one
component produced two symptoms, observed from the lack of sample growth in two
adjacent wells. The positive identification of the anomaly in a reasonable amount of time
was an undeniably positive result in the progress of this research project.

4.3.2

Fluidic Line Failure
As a second test members of the satellite operations team were asked to introduce

an anomaly into the test bed. The rules for anomaly introduction were simple; they were
allowed to fault any component of the fluidics network, any sensor, or the heater. They
were not permitted to introduce a failure into the microcontroller circuit, since it was used
to log the telemetry needed for diagnosis (on the spacecraft a dramatic failure like this
would be diagnosed by inspection).
The anomaly chosen for the test bed was the induced failure of a fluidic line.
Specifically, the line which was connected to well 6 was physically pulled out of the
system and pinched to prevent fluid from unnecessarily spilling out of the test bed. A
photo of the induced anomaly is illustrated in figure 4.12.

Figure 4.12 – Induced Fluid Line Anomaly – The hose connecting the syringe filter to
the input port of well 6 was pulled out and pinched to prevent unnecessary leaking.
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Upon anomaly insertion the experiment was turned on and left to run for 72
hours. When data was collected at the end of the experiment, it was run though the
anomaly manager and the following results were compiled. It is important to note that
the telemetry was directly inserted into the anomaly manager with no functional changes
to remain consistent between test executions. Most importantly the slope threshold used
to determine whether or not a well exhibited growth remained unchanged to validate the
approach for multiple experiments. Figure 4.13 shows the biology growth over the
course of the experiment.

Figure 4.13 – Experiment Growth in 72 Hours – All wells exhibit a downward trend
indicating growth. Well 6’s trend shows a significantly smaller drop, resulting in a
calculated slope below the required threshold thus indicating no growth.
These results are a good example of telemetry that an operator may overlook. Though
each well exhibits a downward trend and to the casual observer points to positive signs of
growth, upon closer inspection the downward trend of well 6 is significantly smaller.
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The initial lower A/D value in well 6 is due to a higher starting cell count while the small
drop in light transmittance over time is due to cells settling on the bottom of the well and
blocking the photodetector. These interpretations need to be reserved for the expert, not
for the operator.
Upon execution of the detection algorithm the optics sensor of well 6 is returned
as a symptomatic component, since its output was not congruent to the simulation’s
predicted growth. The subsequent diagnosis algorithm returned three candidate
components in approximately 9 minutes. Figure 4.14 shows this output.

Figure 4.14 – Prototype Anomaly Manager Output – The well 6 optical sensor shows
a symptom after 36 seconds thus invoking the diagnosis algorithm which offers 3
anomalous candidates in 9 minutes.
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The candidates returned in the diagnosis analysis show a single string failure
somewhere in between the optics sensor and the B-3 valve that did not permit the well 6
biology to grow. When traced serially the sensor, well, and fluidic line are all considered
candidates in preventing growth. It is left up to the operator to determine (if necessary)
which one of these components may have not behaved as expected. Line13 in the model
represents the well 6 fluidic line and is appropriately listed as one of the anomalous
candidates. Figure 4.15 illustrates the anomaly and results returned.
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Figure 4.15 – Fluidic Line Failure – The anomaly manager returned the optics sensor,
well 6, and fluidic line as candidates. Valve B-3 is not a candidate because well 5
exhibited positive signs of growth.
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4.4

PharmaSat Nanosatellite
After development and testing of components, techniques, and algorithms in the

Simple Model and Biological Prototype, the anomaly management tool was expanded
and tested with the PharmaSat nanosatellite after its launch on May 19, 2009. In the
weeks leading up to the launch the tool underwent final revisions based on test data as the
spacecraft’s payload was assembled, checked-out, and qualified for the launch and space
environments. Testing from both before and after launch helped refine the tool and
demonstrate its ability to accurately monitor the conditions of a complex payload with
many components and limited sensing.

4.4.1

Before Launch
Testing before launch helped refine the tool before its integration and use with

flight data. The amount of telemetry available to process from these tests was rather
limited; most of the work done on the payload at this time involved functional checkouts.
Engineers routinely looked at snapshots of data to confirm a healthy system. Having
developed a familiarity with the system in the two years of development leading up to
these checkouts they knew what telemetry to look for. This is an example of expert
system knowledge.
In the days before delivering the satellite to the launch service provider at
Wallops Flight Facility the payload was assembled, checked out, and put through a shock
and vibration test. Figure 4.15 shows the PharmaSat payload being assembled before
functional checkouts were performed.
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Figure 4.15 – PharmaSat Payload Build – An engineer assembling the payload before
acceptance shock and vibration tests.
After payload assembly the functional checkout was successful and the spacecraft
underwent shock and vibrations tests. After the environmental testing another functional
checkout was performed. At this point the engineers observed that three temperature
sensors were reading abnormally high values. Further analysis found that the payload’s
relative humidity had jumped substantially: from 47.3 to 84.9%. After the team was
assembled for multiple hours it was decided that a fluid leak had occurred internally and
the spacecraft had to be disassembled. Upon further inspection it was found that a fluidic
bag developed a pin-hole sized leak during the shock and vibration tests – likely due to
material weakening after the bags were autoclaved for sterilization. Backup circuitry was
installed and fluidic bags were replaced. However, the same autoclaving process that
produced the weak material in the first bag was also performed with the replacement
bags. This meant that a similar leak could develop either during the subsequent shock
and vibration test or during launch. Though the spacecraft then passed the final
acceptance environmental tests, load levels were significantly reduced to prevent
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damaging the hardware. Table 4.1 shows telemetry snapshots of three cases; before the
leak, leak detection, and final payload build.

TimeStamp (4)
CardTemp1 (2)
CardTemp2 (2)
CardTemp3 (2)
CardTemp4 (2)
CardTemp5 (2)
CardTemp6 (2)
CardTempM (2)
FluidicsTemp1 (2)
FluidicsTemp2 (2)
FluidicsTemp3 (2)
FluidicsTempM (2)
SpareTemp1 (2)
SpareTemp2 (2)
Pressure (2)
RelHum (2)
RelHumTemp (2)
Well (1)
Taos_R (2)
Taos_G (2)
Taos_B (2)
StatusByte (1)

Pre Test
10452979
2090
2014
2104
2117
2124
2083
2097
2035
2083
2000
2035
63038
63038
81
1404
6059
16
15564
20000
27397
4

Leak Detection
10546945
1986
1910
2000
4560
4560
4560
3280
1945
1993
1903
1945
63038
63038
59
2700
5957
17
18957
25974
27027
4

Final Build
9507360
2028
2035
1979
2028
2055
2076
2031
2014
2069
2021
2021
63038
63038
82
944
6048
19
14760
27972
20942
4

Table 4.1 – Payload Test Data – Payload telemetry snapshots are shown here before the
leak, as the leak was detected, and upon the final build of the satellite before delivery.
The anomalous temperatures read 45.6 °C when the room was clearly near 20 °C. The
humidity is shown in ADC counts; after the calibration equation is applied readings are
47.3, 84.9, and 31.7 % for Pre Test, Leak Detection, and Final Build columns
respectively. Applying pressure calibration coefficients shows only a slight increase from
14.4 to 14.6 psi and back to 14.4 psi for the final build.
These three snapshots were very useful in refining the anomaly management tool.
After three rounds of testing there existed data which explicitly showed a leak anomaly
and the behavior of the satellite as a consequence. With this knowledge and the
significant possibility of a leak encountered during launch, the detection algorithm was
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updated with new constraints for the environmental parameters such as temperature,
pressure, and humidity to verify system health immediately after launch. Changing the
model to accurately emulate faulty sensor values due to a leak was out of the scope of
this project.
The satellite was successfully delivered and awaited launch for approximately 8
weeks due to various slips including weather and rocket issues. Another major factor for
the experiment was the biocompatibility with the well plate that contained the biology.
Due to manufacturing processes and material selection, the card was not guaranteed to
support live samples past 6 weeks of stasis, a significant source of concern for the team.
Even if the satellite survived launch and deployment, there was a chance that the biology
would not grow at all. While the biocompatibility effects were not modeled in the
anomaly manager (due largely to the lack of characterization in testing), its effects on the
biology could still be detected though not explicitly diagnosed.

4.4.2

After Launch
Within the first 90 minutes after launch the operations team made beacon contact

and was able to determine that the spacecraft was at least at first glance healthy. It was
not until the following day that data was pulled from the spacecraft and analyzed.
Though not much data existed beyond basic performance metrics, when run through the
anomaly management tool a symptom was immediately detected in the relative humidity
field. After the leak observed during testing, the spacecraft was sealed with 31.7%
humidity. Knowing that the spacecraft was launching into a cold case, humidity was
raised to 50% as the predicted value set in the simulation and constraint bounds were
conservatively placed at ±20% humidity. Figure 4.16 shows humidity data from the start
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of the experiment as well as the initial constraining bounds. The output from the
anomaly management tool that is shown to the user is also displayed.
PharmaSat Operational Relative Humidity and Constraints
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Figure 4.16 – Humidity Hazard Detection – Above: Data from the start of the
experiment is shown. Below: A Hazard indicates higher than expected humidity values.
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The anomaly manager successfully detected this symptom soon after launch
which persisted through the stabilization (non-heated) phases of the experiment. Upon
discussion with spacecraft engineers and managers it was determined that although
humidity levels were near those experienced at the time of the leak in testing, a leak had
most likely not occurred. The reason was that as the hardware sat for several weeks
waiting to be launched, some fluid had transpired through the porous membranes on the
well plate and thus contributed to the humidity jump. Had the spacecraft launched soon
after integration, the high humidity levels would be a cause for concern; just as the jump
from 47 to 84% had happened within a matter of a few hours during testing.
As expected during the cold case for the spacecraft the humidity kept climbing,
however when the heaters were enabled the humidity dropped to within the expected
±20% bounds. Nevertheless, bounding conditions were altered to +40/-10% for the
remainder of the experiment and no more humidity-related symptoms existed. Figure
4.17 shows humidity data with re-defined constraints.
PharmaSat Operational Relative Humidity and Constraints
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Figure 4.17 – Humidity Bounds Redefined
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The humidity bounds scenario was a good example of how MBR attempts to
capture expected situations in general models. In this case, the understanding the
majority of the team had from the test data available was that a leak in the payload would
be indicated by a higher than expected humidity reading (and possibly more serious
effects). However, the experiential knowledge that some team members possessed about
fluid transpiration through the membrane was not adequately communicated and thus not
captured in the model. Though the result was only a false alarm, it highlighted the need
of thorough knowledge transfer in future missions from team members responsible for all
subsystems of the spacecraft to model developers.
The remainder of environmental telemetry fields stayed within expected
constraints throughout the duration of the experiment. Pressures remained constant and
fluctuated as expected with temperature as the spacecraft transitioned in and out of
sunlight (Figure 4.18). Most importantly, there was no rapid depressurization, allowing
the biology to metabolize oxygen as it grew.
PharmaSat Operational Pressure and Constraints
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Figure 4.18 – Pressure Data
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Spacecraft temperatures remained within acceptable bounds throughout the
duration of the experiment. Fluid temperatures dropped to the lowest tolerable
temperature of 4.8 °C shortly after launch thus activating the keep-alive heater mode
which controls to 5°C. The lower detection bound was set to 4.5°C and was never
violated. The upper bound was less of a concern, with the limit set to just shy of what the
well plate would be controlled to. Figure 4.19 shows fluidic temperature data for the
entirety of the experiment.
PharmaSat Operational Fluidics Temperatures and Constraints
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Figure 4.19 – Fluidics Temperature Data – The entirety of the experiment is shown
here. Note the lower temperatures during stabilization and the abrupt heating as the
experiment was commanded to start. It is interesting to note that once the fluid was
heated, the fluid heaters were shut off, and heat transfer from the heated well plate kept
the fluid at a relatively constant temperature.
The well plate’s temperature experienced similar conditions as that of the fluidics
system with a few occasions of cold trends which required the keep-alive function to
activate thus preventing the biology from freezing. Upon experiment execution, the
temperature quickly rose to its target median temperature of 27 °C. The median was
controlled to ±.5°C however due to heat conduction it was expected that temperature
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sensors around the card vary by approximately ±2 °C. Therefore these were the
constraints placed in the detection algorithm. Since bounds were phase-specific three
different bounding cases existed as the temperatures stabilized after launch, through the
heating phase, and finally during active heat control. Figure 4.20 shows well plate
temperature data with its respective constraining bounds.
PharmaSat Operational Card Temperatures and Constraints
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Figure 4.20 – Well Plate Temperature Data – Temperature data for the entirety of the
experiment. Constraints were based on the experimental phase of the payload and
changed as heating began, stabilized, and was maintained.
Due to the extended period of time the satellite spent on the launch pad there was
significant concern over the health of the biology as the experiment had started.
Biocompatibility issues had forced a 6 week limit to the amount of time biology was
permitted to remain in stasis. The eight week stasis condition experienced in the actual
mission had never been tested, nor could the team replace the well plate with a new one
given that the satellite was a secondary payload on a rocket that was already stacked and
awaiting launch.
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After launch and the experiment had started and ran for approximately 48 hours
preliminary data was passed through the anomaly management tool. Regression curves
were fit to existing growth data and their slopes were calculated and compared to those of
the modeled system. It was found that all wells had been successfully fed, which meant
that the complex fluidic system operated nominally after launch. At the end of the 96
hour experiment the data were once again passed through the tool with no anomalous
effects detected. It is worth noting that no false positives were identified; the system
experts (the NASA scientists and engineers) also found no major anomalies after
analyzing mission data. Figures 4.21-4.24 show biological data from each dosing case
after the experiment had completed as well corresponding modeled cases.
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Figure 4.21 – Control Well Dosing and Growth – Red, Green, and Blue optics values
are shown respectively as colored points for well 59 in the control bank. No antifungal
was administered. Media dosing is shown by the abrupt change in RGB values.
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Figure 4.22 – Low Concentration Well Dosing and Growth – RGB values are shown
for well 48 in the low concentration bank. As with Figure 4.21, the abrupt initial change
at around the 70 hour time stamp indicates successful dosing as the well went from being
generally clear to being filled with Alamar Blue.

Figure 4.23 – Reference Wells, Real and Simulated – This graphic shows well 36 for
both real and simulated cases along with the curves’ respective regression curves. The
slopes calculated for this case are below the pre-defined threshold indicating no dosing
or growth. It is interesting to note that the minor drop in red optics values is an artifact
of operating temperature and did not affect the dosing and slope threshold calculations.

105

Figure 4.23 shows only one set of simulated reference well telemetry while the
real data clearly shows three. This is because only one simulated set is needed to
compare against all three optics curves. Had a component failure in the fluidics system
prevented other wells from growing, they would look like Figure 4.23. As was seen all
through ground-based testing, upon successful dosing all three color curves exhibited the
abrupt slope change shown in the previous figures. Therefore only one simulated curve
per well sufficed; its output could be used to make all three color comparisons in each
well. Figure 4.24 shows high and medium concentration banks as well as their simulated
counterparts.
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Figure 4.24 – High/Medium Concentrations and Simulated Wells – Wells 11 (a) and
24 (b) shown compared to their respective simulated dosed wells (c) and (d).
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Despite no detected biological symptoms, one set of flat-lined biology data
existed in a reference well that the anomaly diagnosis tool did not find. Upon further
investigation it was determined that one of the reference wells was sacrificed to
accommodate an extra bolt hole – thus blocking the LED/ detector pair, resulting in zerolevel RGB readings on the optics sensor. While this did not affect the experiment or the
anomaly management tool, it once again highlighted the importance of information
transfer from engineers to model developers and console operators. Figure 4.25 shows
the unexpected data.
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Figure 4.25 – Blocked Reference Bank Well 30 – RGB values are measured at zero
counts throughout the duration of the experiment. This is due to the well being sacrificed
to accommodate an extra bolt, thus blocking the corresponding LED/detector pair on the
adjacent circuit boards. This scenario was unanticipated for the model developer and is
a good example of insufficient knowledge transfer.
As a final check the anomaly management tool analyzed data from the payload
and fluidics register files searching for possible misconfigurations. The register file
entries were compared to those generated in the simulation. Discrepancies were flagged
and displayed for the user. Upon misconfiguration detection the diagnosis algorithm was
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not invoked – due largely to parameters that were out of the scope of the simulated model
and that were not immediately tunable on the satellite.
Upon execution of the detection algorithm three potential misconfigurations were
found. These symptoms are shown to start near phases 4 and 8 (register file telemetry
was not downloaded for phases 5-7 due to communications blackouts when the orbiting
experiment was not in range of its ground stations). Figure 4.26 shows the output
presented to the user.

Figure 4.26 – Potential Misconfiguration Output
The three potential symptoms were heater off states during the experiment for
both the fluidics and well plate. Lastly the heat stability flag for the well plate only
activated briefly a few times. The heat stability software flag was set when three
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consecutive temperature readings were within ±.5 °C of the set point. These potential
anomalies have significant implications – for example heater off states and an inability to
maintain temperature control during the biology’s growth phases can be mission-critical.
In this case these warnings were just that; there were no detected hazards associated with
the payload indicating that the temperatures were all within expected bounds. To
reassure themselves the operators could then manually inspect temperature data to find
that heating had occurred nominally.
An explanation for the card heater off state is that the temperature had overshot its
set point and was turned off by the microcontroller. This also explains the card stability
flag not always being set. If the temperature is oscillating beyond its ±.5 °C tolerance
three consecutive readings within the bounds becomes less likely. If anything, this
suggests that perhaps a better thermal control strategy be used in future missions besides
the “bang-bang” on/off scheme employed on PharmaSat to dampen the oscillations.
While these explanations may also be valid for the fluidics heater state, upon
closer inspection it was noticed that a heater ‘on’ flag had never been set throughout the
experiment, though clearly the temperature profiles indicated that the heater operated
nominally. Certainly a possibility is that a register file with this flag set high was not
downloaded during the phases that fluidic heating was occurring, however the other
possibility is that there was a bug in the software and the flag never got set. Though the
first possibility is most likely, due to compressed development schedules and limited
testing the second case cannot be completely ruled out. Model-based tools such as the
one developed in this research can be used not only in operational scenarios but can also
aid in finding unexpected anomalies through the project’s development phase.
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The PharmaSat nanosatellite successfully completed its mission 2 weeks after
launch when primary operations had concluded and stored experimental data had been
downloaded from the satellite.

4.5

Results Summary
The experimental results shown in this chapter validate the use of MBR on a

biological system as a decision support tool. Through the experimentation conducted
both in simulation and with hardware in the loop on the ground and in space, the
approach intended for use with biological spacecraft payloads is shown to be valid. In
the case of prototype ground test hardware failures, one artificially injected into the
system and one unintentional, the anomaly manager detected the anomaly and offered a
list of possible components responsible for the failure. For the valve failure case, only
one component was returned as the logical culprit, while the failed growth case was
narrowed to 3 candidates. Though the spacecraft operated nominally, several warning
conditions provided further insight into the operations of the MBR tool and the satellite
itself.
While processing times increased with system complexity, they are still within
acceptable bounds given the mission operations scenario of only needing to diagnose
anomalies near real-time. Some level of system knowledge was necessary to understand
the candidate list; however a high level understanding was sufficient.
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5.

Conclusions
This chapter summarizes the research presented in this thesis. Additionally a

roadmap for future work is laid out referring to upcoming heritage-based biological
payload spacecraft currently in development. Finally, lessons learned are discussed to aid
in future anomaly management research.

5.1

Summary
The objective of this thesis was to demonstrate the feasibility of using model-

based reasoning techniques as an aid to a human operator for detecting and diagnosing
possible anomalies in the biological payload of a spacecraft. An existing graphical
modeling environment was extended through the creation of new component blocks that
can now accommodate factors such as fluid flow and biological growth. The nature of
the modeling scheme is such that these behaviors can be applied to any engineering
system, not just a biological incubation instrument. Additionally, this research continued
to standardize the MATLAB and Simulink software packages for development of
reusable models and component blocks for anomaly management applications. Finally
this research also includes (to the author’s knowledge) the first use of MBR with the
biological payload of a spacecraft.

5.2

Lessons Learned
The Model-Based Reasoning technique is very effective in compiling in-depth

design knowledge from many subsystems to characterize a system’s behavior and
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accurately diagnose anomalous events. The ability of this system to reason on telemetry
generated by an engineering system aids the user in developing a gut feel for advanced
teleproprioception.
It is important to note that the time spent developing this tool was extensive; it is
clear why many industries may not immediately strive to use this approach for their
particular applications. Experts who have worked on different aspects of the design and
development can suffice for anomaly diagnosis if they are available. Since the anomaly
manager will reduce the time it takes for a possible diagnosis, opting to not use such a
system involves a trade between development time and cost versus diagnosing time spent
on ‘manual’ anomaly resolution. For some engineering applications, the upfront
investment of developing an anomaly management system may save money during
operations when time is a critical factor in anomaly resolution. An example would be
trying to minimize the downtime of an assembly line process by using the anomaly
manager to narrow down a list of candidate components which may be faulted,
misconfigured, or operating out of expected bounds.
One suggestion for future development of anomaly managers would be to design
them in parallel with the actual system. Building both the model and real system
concurrently offers a unique way of embedding design knowledge into the model, and
lessons learned from simulation modeling can positively impact the design of the real
system.
A lesson to learn from concurrent model development is observability. When
modeling sensors and generating simulated telemetry an evaluation should be performed
as to whether or not anomalies are easily detected in the current design. If they are not
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observable with respect to the anomaly manager, they will not be observable in the real
system. In this way, concurrent model development will aid the design of the actual
system, where design iterations can be performed to either embed more sensing or force a
system redesign so as to yield definitive answers for when a component operates
anomalously.
Lastly, a heavy importance must be placed on ease of use; the operator should not
need to have expert knowledge of the anomaly manager to be able to run it. Intuitive user
interfaces should be just as important to develop as the system model itself.
These lessons learned were important in the development of this research tool and
will aid in future implementations as more systems are evaluated and modeled. The
experimental results as well as the use of this system on the PharmaSat flight experiment
were valuable in demonstrating the usefulness of MBR research and unquestionably
justify continued investigations into this field.

5.3

Future Work
With the objectives listed in Chapter 1 completed, the short term focus for future

work should be for continued verification and refinement of this decision aid tool as it is
modified and adapted for use in mission operations. Running the anomaly manager on
ground data and comparing to flight results could yield insights into microgravity effects.
Other tasks include the ability to simulate anomalies mid-experimental phase and to only
simulate a subset of all phases to reduce processing time. Incorporating reduction
algorithms to upstream candidate lists will also speed up the diagnosis process.
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A significant amount of time can be spent on trying different approaches to
qualitatively measure the behavior of the biological experiment over time. This may
include a departure entirely from curve fitting, derivatives, and thresholding. Higher
fidelity models can have variables that include higher antifungal concentrations,
contamination, evaporation, depressurization, and subtle temperature effects. Ultimately
a trade needs to be considered for the effort to incorporate higher fidelity modeling vs.
the increased development time and the gain that this effort will bring to the project.
Other interesting additions to this research can involve more comprehensive
modeling by ways of anomalously created structural connections. The example presented
in Chapter 4 discussing temperature sensor anomalies caused by a fluid leak highlighted
the need for dynamically generated connections which may add to the fidelity of a
modeled anomaly. Likewise, having the ability to explicitly control simulated
configurations would allow misconfiguration states to be included in the diagnosis
algorithm rather than being left for inspection by the human upon detection.
For the longer term this research needs to be expanded to the application of
PharmaSat’s follow-on missions such as O/OREOS (Organism/ ORganics Exposure to
Orbital Stresses), launched on November 19, 2010. Developed by the same group at
NASA Ames Research Center, this nanosatellite has two separate biological experiments
aimed at studying the effects of microgravity and radiation on biological strains as well as
organic samples. Though the chassis and bus were essentially re-flights of GeneSat-1
and PharmaSat, a higher altitude, inclination, and required 6 month mission lifespan will
elevate the spacecraft’s radiation doses – a condition not yet experienced on this family
of nanosatellites. With Santa Clara University performing ground operations for this
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mission, the need to characterize possible anomalous behaviors of the bus and payloads is
of high importance for timely diagnosing and resolving actions. Though already
launched, the opportunity to implement an anomaly manager for this satellite is a viable
short-term goal.
Upcoming missions such as ECAMSat, MisST, and SporeSat would also benefit
from a similar anomaly management system. Each of these experiments is unique and
carries potential risks that could lead to anomalous behavior possibly jeopardizing the
mission. The use of an anomaly management system could help lower the risk of
operating the spacecraft with an undetected or poorly characterized anomaly.
Adaptations of the system developed for this thesis concentrate on the mission operator
as the decision-maker when anomalies are detected and diagnosed. Further in the future
the application of onboard anomaly management with automated resolving actions could
ultimately lower the risk that is inherently carried in small satellite applications with little
to no redundancy. The trade for this more immediate resolving capability is of course the
extensive development time required to adequately validate and verify the system will
perform adequately without posing significant risks to the spacecraft.
The application of this research to a multitude of other engineering systems is
possible thanks to a concretely laid out theoretical framework built into a modular and
adaptable graphical environment. However currently this framework does not
necessarily extend to model development itself, therefore the creation of steps a
developer can take to abstract system behaviors and parameters into a hybrid model such
as the one presented in this thesis would help streamline the production of future MBR
research platforms.
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Appendix
A.1 – PharmaSat Fluidics Network Diagram
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Simulink PharmaSat Payload Model

120

A.T.1 – PharmaSat State Machine
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A.2 – Biological Prototype Documentation

Phase
1.) Periodic Recirculate
*Until Start Expr. Button
2.) Periodic Recirculate
*Until Heat Condition Met
3.) Dose Banks 1-2
4.) Dose Banks 3-4
5.) Dose Banks 5-6
6.) Diffusion Time Allowance
7.) Dose Banks 1-2
8.) Dose Banks 3-4
9.) Dose Banks 5-6
10.) Growth Time Allowance
*Optics and Heat Control
Active
*Fluidics Park and Shutdown

Pump
X

V1

V2

V3

X
X
X
X

X

X
X
X

X

X
X

X
X

V4
X

Heater

X

X
X
X
X
X
X
X
X
X

X

Duration
(sec)
TBD
TBD
10
10
10
60 min
10
10
10

40 hrs

Table A.2.1 – Prototype Experiment State Conditions – Each sub phase is illustrated
in this table with corresponding component actuation indicated by an ‘X’ and
corresponding time duration. A blank box indicates an ‘off’ state.
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A.3 – Functional Component Models
One of the major goals of this research project was to create reusable component
blocks which could be used in the modeling of a variety of biological payload designs in
a spacecraft not only for the PharmaSat mission but follow-on missions with similar
experimental layouts. As discussed in Chapter 2, the main components of the biological
experiment consists of pumps, valves, fluidic lines, specimen wells, media bags, heaters,
sensors, microcontrollers, and a number of passive components. The modeling of these
components is shown here, their implementation in the system model is shown in Figure
A.1, and their usage in the model is discussed in the subsequent section.
The microprocessor (Figure A.3.1) in the model simulated functionality of both
PICs in the PharmaSat payload and both BASIC Stamps in the biological prototype. This
was done as a way to simplify an already complex model while still offering the statemachine event-based actuation required for the experiment’s components. Additionally,
the use of two microcontrollers on these systems was selected based on individual
memory allocation limitations; these were not issues with the MATLAB simulation. The
modeled controllers emulating the PharmaSat and prototype experiments were configured
slightly differently based on the number of components actuated and phases executed, but
their overall behavior remained analogous.
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(a) Masked View

(b) – Unmasked View
Figure A.3.1 – The Modeled Microcontroller – (a) - The view offered to the user. The
desired phase of simulation can be directly manipulated. (b) – Control outputs shown
going to the model’s actuated components.
This component was responsible for maintaining the modeled phase of the
experiment by means of heater set points for the fluidics network and the well plate (tasks
handled by the payload processor in the real system) as well as the actuation of 2 pumps
and 13 valves (given to the fluidics processor). The user is able to select specifically
which phase of the experiment they would like to execute. Entering a ‘0’ will
sequentially execute all phases. The experimental phases are modeled after the state
diagrams in appendix A.T.1 and are further discussed in Chapter 3.5.
Rather than directly connecting fluidic components together in the system model,
blocks representing the Tygon tubing used in the actual system were created as a way of
not only modeling the fluid flow with more fidelity, but as a way of calculating dilution
concentrations throughout the fluidic network. These tubes were responsible for passing
fluidic information through while calculating and updating their volumetric dilution ratio
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of growth media to antifungal solutions. The antifungal concentration is simply defined
as:
concentration = (volume of antifungal)/ (volume of growth media + antifungal)
The updated concentration therefore is based on the equation:

updated concentration = ((current concentration)*(line volume) + (pumped
concentration)* (pumped volume))/ (pumped volume + line volume)

The fluidic state of the line is then updated with the new concentration value and the
volume is assumed to remain the same (i.e. no bubbles or inconsistencies) with the excess
pumped to the next component along with an updated concentration value. The volume
of the fluidic line is defined in the block parameters dialog box and additionally accounts
for hold-up volumes of the valves and pumps connected to the lines. This is done since
these components are only modeled to direct fluid flow signals. Figure A.3.2 shows the
model block with its corresponding dialog parameter box.

(a) – The Fluidic Line Model Block

(b) – Fluidic Line Block Parameter Box

Figure A.3.2 – The Fluidic Line Block Model
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Media and waste reservoirs act similarly to fluidic lines in the sense of monitoring
fluid volumes and concentrations. The main difference is that their volume is not
assumed to be static – rather it is constantly recalculated based on its inputs and outputs.
The concentration in the bag is also recalculated and updated in the simulation. Figure
A.3.3 shows both types of reservoirs; one dedicated to holding experimental media and
one used to collect waste fluids.

(a) – Antifungal Media Bag

(b) – Large Waste Bag

Figure A.3.3 – Media and Waste Bag Models
The valve models were created to emulate the functionality of those used in
PharmaSat and the biological test bed prototype. In same way the real solenoid valves
route fluid to the NC or NO port from the common port based on an applied voltage, the
modeled block routed data to one port or the other in much the same way based on a logic
1 or 0 signal. In the PharmaSat system, the same valves were implemented in two
fashions; A-type valves had a sealed NO port, essentially acting only as ON/OFF valves
with the one remaining port, while B-type valves remained unmodified. These behaviors
were accounted for in the modeling, and Figure A.3.4 shows both types of model blocks.
The valves were additionally given environmental parameters such as temperature and
pressure constraints. To aid the user the foreground color of the block is programmed to
change from blue to red when actuated so as to help oversee correct execution.
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Figure A.3.4 – Modeled A-Type and B-Type Valves - The microcontroller sends a 1 or
0 signal to (a) making the valve route the modeled fluid flow from (b) to (c) or (e) in the
case of a B valve, and from (b) to (c) or no flow in the case of an A valve. Requested
volume paths exist for each line shown in (d).

The stepper pump model (P2 in PharmaSat component nomenclature, Figure
A.3.5) is designed to dispense metered quantities of media through the simulation based
on desired inputs from the microcontroller. Each step of the motor dispenses .1 µL of
media based on the pump’s piston throw. The motor can be stepped in both directions
which either aspirates fluid into the pump cylinder or dispenses the fluid out into the
network.

(a) – Masked View
(b) – Unmasked View
Figure A.3.5 – Modeled Stepper Pump
The frequency that the motor is stepped at corresponds to the speed at which the
piston is moved, but has no effect on the volume dispensed. Only the amount of steps
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taken in a given direction governs this, so even though the desired frequency is passed to
the pump model this value is not immediately considered. The control signal itself is a
vector of double precision digits with the following format:
P2_state = [P2_direction P2_frequency P2_steps]
P2_direction can be [0, 1, 2] making the pump stop, dispense, or aspirate respectively.
P2_frequency and P2_steps are based on the desired pump frequency and step quantity
specified in Appendix Table A.T.1. The working volume is calculated by multiplying the
number of steps by .1 to convert into µL. To prime the piston cylinder, aspiration is
always done first. When aspirating, the pump draws fluid into its chamber, therefore
propagating the required volume value back to the appropriate media reservoir (based on
corresponding valve states) and remains in standby until this value is passed back into the
pump. With the virtual cylinder primed the stepper pump is ready to dispense. When the
dispense command is given by the microcontroller this volume is propagated around the
components of the fluidic network. One aspiration/ dispensation iteration is discussed in
Figure A.3.6.
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Figure A.3.6 – Stepper Pump Progression – Once a control vector has been sent to the
pump the required aspirated volume is computed and sent from (a). It passively flows
through (b) and into valve B4. B4’s common port is connected to the stepper pump while
its NO port leads to the Antifungal bag (a red valve block would indicate a NC port
connection to the Dilution bag). The required volume is therefore also passed out the NO
port down (c) and (d) where the Antifungal Bag dispenses this amount and updates its
volume and concentration values. This dispensed volume flows through (e), (f), (g), and
(h) while updating concentrations in the fluid lines along the way. Having reached the
pump, the volume is primed and dispensed upon acquisition of the appropriate ‘dispense’
control vector.

The growth of the simulated biology is a function of such parameters as
temperature, pressure, humidity, and growth media. To aid in some system simulations, a
growth curve model was developed using regression models based off of the GeneSat-1
experiment’s E. coli optical density curves. As discussed in Chapter 1, the modeling of
Saccharomyces cerevisiae for the PharmaSat experiment can be done on an in depth
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scale; however the sensing of many growth attributes is required for proper model
verification. These experiments contained a different kind of sensing which did not allow
for this nature of modeling. Rather, in the model used for this research the biology
growth curves were fitted to polynomial trend lines. These trend lines were then passed
through a number of scripts for interpretation with the goal of detection and diagnosis of
anomalous growth attributes.
The simulated biology growth was directly incorporated into the well plate blocks
with corresponding temperature sensors, and optics detectors. Each well contained its
own regression-based biological curve, along with a running calculation of volume and
concentration of growth media/ antifungal administered. The curves were then generated
based on these values. The output of the wells then was picked off by the temperature
and optics sensors which passed the data to a telemetry file writer. A heater driven by the
microcontroller set the temperature of the well plate and fluidics based on which phase
the experiment was undergoing. Figure A.3.7 shows a simple one-well setup and its
associated simulated telemetry plot. Additionally each of the sensors was configured for
possible anomalous states.
Simple Model: Well 1 Telemetry
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Temp(C)/ OD Counts
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100

50

0

-50

Figure A.3.7 – Biological Well Model
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After all system telemetry was generated, the values were passed to a function
block responsible for writing data to a text file. This text file would then be loaded and
interpreted once detection and diagnosis were executed. The telemetry writer block
contained two modes: sim_telem and eval_telem. When in sim_telem mode the text file’s
output was set to be named “sim_telemetry.txt” which represented simulated telemetry in
nominal operation. This data was used for comparisons with that of the real system to
find symptoms. Upon symptom detection and model reevaluation subsequent telemetry
entries would be written to “eval_telemetry.txt” under eval_telem mode. This was done
so as to preserve sim_telemetry.txt without deleting or overwriting it (useful for running
the tool multiple times). Figure A.3.9 shows the telemetry writing block.

Figure A.3.8– Telemetry Writing Block
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